Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
1616796	cb-vekaas	— (—)	9234	32971	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diabetes, insulin treatment (Kela reimbursement)

2262

5532

2.56

321.02

4.4

3.2

—

Diabetes mellitus

2237

5307

2.57

318.55

4.2

3.1

—

Covid-19 confirmed case

903

2293

4.15

316.39

5.1

3.4

—

Other respiratory disorders and diseases

753

1679

4.81

314.58

8.1

3.2

—

Other diseases of the respiratory system

753

1679

4.81

314.58

8.1

3.2

—

Diabetes, varying definitions

2218

5313

2.55

310.66

4.2

3.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2162

5038

2.68

307.65

4.4

3.2

—

COPD/asthma related infections

2226

4072

2.79

307.65

4.2

2.8

—

Implicit bacterial Sepsis

1298

2743

4.59

307.65

6.2

2.8

—

Endocrine, nutritional and metabolic diseases

1704

2807

3.15

307.65

3.9

2.8

—

Heart failure and antihypertensive medication

892

789

7.94

307.65

6.2

2.5

—

Acute tubulo-interstitial nephritis

1436

4010

3.27

307.65

5.1

2.6

—

Dialysis, with operation codes

740

793

10.74

307.65

10.4

3.0

—

Sleep apnoea

2143

5489

2.72

307.65

3.8

3.5

—

All-cause Heart Failure

1735

3445

3.81

307.65

5.5

3.1

—

Heart failure,strict

1633

2716

4.57

307.65

5.7

2.7

—

General symptoms and signs

2488

4514

2.82

307.65

3.8

3.3

—

Bacterial Sepsis

1438

3085

4.37

307.65

6.1

2.8

—

Hypertensive diseases

1750

3048

3.33

307.65

4.7

2.6

—

Other disorders of fluid, electrolyte and acid-base balance

1077

2134

5.19

307.65

5.1

3.4

—

Nephropathy related operations

739

926

9.24

307.65

10.6

3.5

—

Secondary hypertension

461

272

19.17

307.65

9.0

1.9

—

COPD (mode)

937

1438

5.44

307.65

5.2

2.9

—

Oral corticosteroids

2482

5943

2.58

307.65

4.4

3.1

—

Metabolic disorders

2262

5082

2.84

307.65

4.4

3.3

—

Dyspnoea

2249

6027

2.94

307.65

4.3

3.4

—

Abnormalities of breathing

2234

4346

3.13

307.65

4.0

3.3

—

Fever of other and unknown origin

1597

3664

4.20

307.65

4.8

3.3

—

Heart failure, strict

1771

3497

3.82

307.65

5.6

3.1

—

Respiratory insufficiency

444

363

13.89

307.65

9.6

2.6

—

Asthma, unspecified (mode), excluding more controls

1138

2088

4.41

307.65

4.0

2.6

—

Chronic kidney disease

1692

2201

8.63

307.65

7.4

2.9

—

Transplanted organ and tissue status

481

564

9.60

307.65

9.9

3.3

—

Type 2 diabetes, wide definition

2034

4321

3.17

307.65

4.7

3.2

—

Care involving dialysis

555

507

13.15

307.65

11.1

3.4

—

Persons encountering health services in other circumstances, wide

2799

5705

2.60

307.65

4.5

3.1

—

Extracorporeal dialysis

408

430

11.43

307.65

10.9

3.8

—

Asthma, excluding more controls

1461

2333

3.41

307.65

3.9

2.6

—

Persons encountering health services in other circumstances

1385

2695

5.44

307.65

4.0

3.0

—

First line medication for Crohn's disease

2551

5341

2.66

307.65

4.6

2.8

—

Persons encountering health services for specific procedures and health care

2457

5972

2.61

307.65

5.2

2.8

—

Presence of other functional implants

1601

3434

3.43

307.65

4.1

3.5

—

Septicaemia

1348

3178

4.30

307.65

5.9

3.3

—

Sleep disorders (combined)

2290

5769

2.67

307.65

3.7

3.5

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2697

5593

3.50

307.65

4.9

2.9

—

Hypertension

1749

3046

3.33

307.65

4.7

2.6

—

Renal tubulo-interstitial diseases

2988

5087

4.73

307.65

5.7

2.6

—

Other septicaemia

1239

2876

4.47

307.65

6.0

3.3

—

COPD/asthma/ILD related infections

2226

4072

2.79

307.65

4.2

2.8

—

Implicit viral Sepsis

659

1248

5.64

307.65

6.5

2.8

—

Pneumonias (Asthma/COPD co-morbidities)

2798

5533

3.62

307.65

4.9

2.8

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2561

4066

4.09

307.65

4.9

2.8

—

Hypertensive diseases (excluding secondary)

1241

1529

4.86

307.65

4.9

2.1

—

Other heart diseases

1052

1584

4.51

307.65

5.2

2.2

—

Glomerular diseases

829

1375

6.63

307.65

8.2

3.5

—

Renal failure

2237

3156

7.15

307.65

6.7

2.9

—

Cardiovascular diseases (excluding rheumatic etc)

1280

2064

3.66

307.65

4.5

2.1

—

Other bacterial diseases

2569

5536

3.32

307.65

4.9

3.1

—

All pneumoniae

2808

5566

3.60

307.65

4.9

2.8

—

Anaemias

735

346

14.83

307.65

5.5

2.1

—

Other diseases of pleura

1498

3512

3.99

307.65

6.0

3.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1702

5250

3.10

307.65

5.0

3.4

—

Asthma, unspecified (mode)

1164

2419

3.92

307.65

4.0

2.7

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2582

6037

3.16

307.65

4.7

3.2

—

Influenza and pneumonia

2835

5528

3.48

307.65

4.9

2.8

—

Heart failure, not strict

2335

3827

4.41

307.65

5.8

2.7

—

Insulin, fast-acting or short human

1131

3202

3.70

307.65

5.4

3.3

—

Insulin, intermediate and long-acting

1537

4875

3.21

307.65

4.9

3.4

—

Viral Sepsis

659

1250

5.63

307.65

6.5

2.8

—

Insulin medication

1700

4398

3.43

307.65

5.0

3.4

—

Implicit Sepsis

2276

4463

4.14

307.65

5.6

2.7

—

Sleep apnoea, including avohilmo

2220

5551

2.66

307.65

3.7

3.5

—

Insulin, fast-acting

1124

3011

3.91

307.65

5.4

3.3

—

Explicit Sepsis

1391

3094

4.54

307.65

5.9

2.8

—

Kidney transplant status

351

313

13.49

307.65

10.9

3.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2395

4823

3.74

307.65

5.4

2.7

—

ILD medications: prednisolone, methylprednisolone, prednisone

2556

5621

2.63

307.65

5.0

2.8

—

ILD medications

2551

5701

2.51

307.65

4.9

2.8

—

Malaise and fatigue

1364

2995

3.94

307.65

3.6

3.4

—

Pneumonia, organism unspecified

2664

5124

3.90

307.65

5.0

2.8

—

Acute renal failure

918

1382

7.31

307.65

6.6

2.9

—

Glomerular disorders in diseases classified elsewhere

588

856

7.72

307.65

8.3

3.5

—

2561

4066

4.09

307.65

4.9

2.8

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2151

5660

2.64

307.65

5.0

3.1

—

L04AD Calcineurin inhibitors

487

682

7.93

307.65

9.6

3.6

—

Bacterial infection, other or unspecified

1363

3843

3.32

307.65

5.0

3.2

—

Hypertension, essential

1723

2968

3.40

307.65

4.3

2.6

—

Dialysis

283

219

15.73

304.64

12.0

2.8

—

Any reimbursement code in KELA

1065

1297

4.19

303.30

4.0

1.9

—

Other medical care

1099

3210

3.48

299.15

4.6

3.0

—

Inflammatory bowel disease treatment related agents

2504

6123

2.37

297.21

4.6

3.1

—

Asthma

1523

2690

3.10

293.39

3.9

2.7

—

Heart failure and bmi 25plus

1092

2157

3.67

288.26

5.7

3.1

—

Diabetes medication

2189

5550

2.45

283.66

4.3

3.2

—

Type 2 diabetes

2077

5006

2.51

283.14

4.2

3.1

—

COPD

1226

3280

3.21

280.08

5.1

3.4

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

400

336

9.37

277.91

5.5

3.2

—

Aplastic and other anaemias

1221

3847

3.13

277.39

5.3

3.5

—

Asthma (only as main-diagnosis), excluding more controls

1258

2333

3.27

274.64

3.7

2.6

—

Early onset COPD, excluding more controls

553

1067

5.43

271.78

5.4

3.0

—

Any gastric operation

1633

2919

2.86

269.16

4.2

2.5

—

GASTRO-related operations

1633

2919

2.86

269.16

4.2

2.5

—

ILD medications: immunosuppressive drugs

1346

4630

2.86

265.15

6.0

2.8

—

Other pulmonary diagnosis

1551

2715

2.91

264.11

4.0

2.7

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

572

716

5.80

263.99

5.7

2.2

—

Other heart diseases, wide

1840

4551

2.56

263.24

4.7

2.9

—

Other chronic obstructive pulmonary disease

1165

3175

3.17

262.08

5.2

3.4

—

Excluding asthma or asthma-COPD overlap

1537

2715

2.89

257.70

4.0

2.7

—

Hypothyroidism (congenital or acquired)

491

392

7.36

255.23

3.5

2.0

—

Depression medications

548

411

6.85

250.43

3.1

1.8

—

COPD differential diagnosis

1519

2713

2.85

249.84

4.0

2.7

—

Hypothyroidism and >3 levothyroxin purchases

482

389

7.29

248.86

3.4

2.0

—

Hypothyroidism, levothyroxine purchases

482

389

7.29

248.86

3.4

2.0

—

ILD differential diagnosis

1516

2712

2.85

248.62

4.0

2.7

—

Cardiovascular diseases

1145

1916

3.32

247.12

4.3

2.1

—

Other and unspecified anaemias

1097

3577

3.08

244.30

5.0

3.5

—

Other anaemias

1104

3608

3.07

243.55

5.0

3.5

—

Asthma (only as main-diagnosis)

1298

2690

2.97

242.65

3.8

2.7

—

Unspecified kidney failure

389

612

6.95

239.49

6.6

3.1

—

COPD, hospital admissions

1189

3529

2.96

238.88

5.2

3.5

—

Disorders resulting from impaired renal tubular function

251

237

13.01

238.86

9.8

3.8

—

Other chronic obstructive pulmonary disease, including avohilmo

1320

4073

2.79

237.37

4.9

3.5

—

ILD, hospital admission 2, with pulmonary infections

355

515

7.51

235.61

5.9

3.0

—

Bronchitis

2210

6659

2.22

234.44

4.5

3.2

—

Non-ischemic cardiomyopathy

772

1717

3.85

232.54

5.5

2.9

—

Substance abuse, excluding more controls

1270

4107

2.78

231.73

3.8

3.6

—

COPD, early/later onset

1182

3548

2.92

231.40

5.2

3.5

—

Type 1 diabetes, wide definition, subgroup 1

587

1367

4.48

229.85

5.4

3.3

—

Diabetic nephropathy, excluding more controls

585

1097

4.84

229.84

7.2

3.1

—

Disorders of other endocrine glands

1046

3497

3.04

229.73

5.1

3.3

—

Antihypertensive medication - note that there are other indications

1132

1996

3.16

227.27

4.5

2.2

—

Atrial fibrillation and flutter

642

936

4.60

226.94

4.7

2.2

—

Hypo-osmolality and hyponatraemia

531

1165

4.82

224.64

4.7

3.4

—

Asthma (mode)

1362

2712

2.81

224.59

3.6

2.7

—

Tramadol

1607

4190

2.51

224.53

4.1

3.3

—

COPD, hospital admission 2, with asthma infections

914

2439

3.34

224.41

5.8

3.4

—

Type 1 diabetes

675

1777

3.94

223.35

5.5

3.3

—

Type 1 diabetes, wide definition

604

1485

4.23

220.00

5.4

3.3

—

Viral pneumonia

411

742

5.91

218.71

5.9

3.1

—

Acute bronchitis

1037

3533

2.97

218.50

5.2

3.4

—

Symptoms and signs involving the circulatory and respiratory systems

1987

4361

2.32

218.48

3.6

3.2

—

Cardiac arrhythmias

1078

2388

3.04

216.42

4.0

2.7

—

Atrial fibrillation and flutter with reimbursement

547

704

5.14

216.21

4.2

2.2

—

Oxycodone

872

2673

3.27

215.39

4.5

3.5

—

COPD related to multimorbidity

1045

3048

3.00

214.70

5.3

3.5

—

Later onset COPD, excluding more controls

559

977

4.69

212.32

5.1

2.8

—

Provisional assignment of new diseases of uncertain etiology

1046

3724

2.89

211.68

5.0

3.3

—

Codes for special purposes

1047

3730

2.89

211.62

4.9

3.3

—

Invasive ventilation

330

501

7.34

211.20

7.6

3.6

—

L04AA Selective immunosuppressants

618

1601

4.06

210.68

8.1

3.3

—

Other acute lower respiratory infections

1252

4659

2.63

209.71

5.1

3.4

—

Codeine

1880

4553

2.31

209.61

3.6

3.2

—

Pulmonary heart disease, diseases of pulmonary circulation

845

2690

3.27

209.49

4.7

3.5

—

Other antidepressants

2154

5222

2.19

209.10

3.8

3.5

—

Bleeding

1762

5696

2.30

208.27

4.6

3.5

—

ILD, hospital admissions 3, with pneumonia sepsis

324

490

7.26

207.38

6.2

3.1

—

Certain infectious and parasitic diseases

1931

4288

2.29

206.31

4.4

2.7

—

Parasetamol

1572

3243

2.51

205.95

3.8

3.2

—

Nausea and vomiting

678

1867

3.71

204.56

4.7

3.5

—

Other nutritional deficiencies

1309

5195

2.52

201.91

4.8

3.3

—

Infections, IBD-co-morbidities

393

469

6.33

201.27

6.1

2.9

—

Valvular heart disease excluding rheumatic fever

1002

2509

3.00

200.60

4.9

3.0

—

Opioids

1943

4625

2.24

200.15

3.8

3.2

—

Type 2 diabetes, definitions combined

1807

4824

2.27

199.39

3.8

3.1

—

Non-rheumatic valve diseases

993

2488

2.99

198.18

4.9

3.1

—

Intracranial trauma

1110

3034

2.79

197.81

3.7

3.5

—

Episodal and paroxysmal disorders

2183

5346

2.12

196.45

3.6

3.5

—

Type 2 diabetes, strict (exclude DM1)

1812

4881

2.26

196.01

3.8

3.2

—

Mental and behavioural disorders due to psychoactive substance use

1336

5226

2.47

195.95

3.7

—

Hyperlipidaemia, other/unspecified

920

3011

2.99

194.52

4.2

3.4

—

Benzodiazepine use

2010

6898

2.11

192.52

4.0

3.4

—

Pain in throat and chest

1586

4172

2.36

192.15

3.5

3.3

—

Erysipelas

1170

4189

2.61

191.50

4.9

3.2

—

Glucagon-like peptide-1 (GLP-1) analogues

1216

3962

2.60

191.23

4.6

3.5

—

Other dialysis

207

204

12.38

191.17

12.9

4.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

773

2048

3.36

191.12

6.1

3.4

—

Gout

773

2223

3.31

190.50

5.8

3.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

756

1383

3.53

189.35

4.3

2.1

—

Chronic lower respiratory diseases

2359

6415

2.02

188.70

4.2

3.3

—

2204

5692

2.08

188.59

4.3

3.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

598

1630

3.78

188.02

3.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2060

5662

2.11

186.75

5.0

3.1

—

Convulsions, not elsewhere classified

553

1415

3.99

186.62

4.0

3.5

—

Pleural effusion

487

1162

4.46

186.47

5.0

3.1

—

Type 2 diabetes, definitions combined, including avohilmo

1783

4826

2.22

186.43

3.8

3.1

—

Other (not insulin) diabetes medications

1843

5166

2.19

186.01

3.9

3.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

1472

5897

2.31

185.81

4.7

3.2

—

Obesity due to excess calories

975

3587

2.79

185.31

4.8

3.3

—

Cerebrovascular diseases (FINNGEN)

573

1019

4.12

183.98

4.4

2.2

—

Obesity

1227

5009

2.48

183.81

4.8

3.3

—

Obesity and other hyperalimentation

1230

5031

2.47

183.16

4.8

3.3

—

Extreme obesity with alveolar hypoventilation

213

229

10.72

183.08

7.7

2.9

—

Other disorders of kidney and ureter

441

991

4.78

182.96

8.2

3.8

—

Asthma-related infections

1266

5222

2.44

182.53

4.4

3.5

—

Asthma, hospital admission 2, infections

1266

5222

2.44

182.53

4.4

3.5

—

1296

5054

2.41

179.25

3.7

—

1342

5172

2.38

179.19

3.8

3.7

—

Exposure to unspecified factor

1906

7237

2.08

178.96

4.2

3.4

—

Glomerulonephritis

370

735

5.44

178.04

8.0

3.8

—

Substance abuse

1270

5151

2.41

177.27

3.8

3.7

—

Iron deficiency anaemia

951

3509

2.77

176.38

4.9

3.3

—

Obesity related asthma

783

2634

3.08

176.25

4.5

3.6

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

928

2961

2.84

175.92

3.5

3.7

—

Polyarthropathies

1459

4268

2.32

173.65

4.8

3.4

—

Nutritional anaemias

1078

4179

2.58

173.63

4.8

3.4

—

Pulmonary embolism

741

2447

3.15

172.61

4.4

3.5

—

Intestinal infectious diseases

1846

7044

2.07

172.54

4.6

3.3

—

Gout, FINNGEN

773

2623

3.07

172.09

5.8

3.6

—

Concussion

932

2961

2.78

171.36

3.5

—

Complications of surgical and medical care, not elsewhere classified

1903

6753

2.06

170.59

4.4

3.4

—

Poisoning by drugs, medicaments and biological substances

581

1664

3.62

170.30

3.6

3.5

—

355

706

5.28

169.13

4.6

2.9

—

Hypokalaemia

356

713

5.31

168.96

4.1

3.4

—

Pulmonary heart disease

741

2484

3.10

168.17

4.4

3.6

—

Mental and behavioural disorders due to alcohol

1141

4633

2.46

166.28

3.7

—

Poisoning by medicine

540

1498

3.75

166.21

3.6

3.5

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

447

1087

4.30

165.97

3.6

3.4

—

Other CVD (FINNGEN)

279

318

7.25

165.88

4.3

2.1

—

Codeine or tramadol medication

2202

6289

1.97

165.27

3.7

3.5

—

Personality disorders, excluding more controls

526

1441

3.76

164.22

3.7

3.4

—

Gout, idiopatic and unspecified

668

2154

3.25

162.90

6.0

3.6

—

Asthma-related pneumonia

853

3160

2.78

160.07

5.1

3.5

—

Gout, strict definition

532

1510

3.73

159.69

6.1

3.7

—

Asthma-related pneumonia or sepsis

853

3166

2.78

159.45

5.1

3.5

—

Asthma, hospital admissions 3, pneumonia

853

3166

2.78

159.45

5.1

3.5

—

Gout, unspecified

578

1733

3.52

159.10

6.1

3.7

—

Autoimmune diseases excluding thyroid diseases

1985

5557

2.01

158.50

4.4

3.2

—

Alcohol use disorder, Swedish definition

1206

4869

2.35

158.42

3.9

3.7

—

Neurological diseases, wide definition

573

720

4.07

158.01

3.7

2.7

—

Venous thromboembolism

1154

4816

2.38

157.24

4.3

3.5

—

Autoimmune diseases

2126

5591

1.97

156.66

4.2

3.2

—

Other respiratory diseases principally affecting the interstitium

525

1495

3.71

156.56

5.7

3.6

—

Diabetic nephropathy

588

1791

3.49

155.85

7.2

3.6

—

Neurological diseases

1627

3817

2.18

155.08

3.6

3.4

—

Volume depletion

315

614

5.50

154.54

5.5

3.6

—

Contact with and exposure to communicable diseases

648

2113

3.14

152.22

3.5

3.4

—

Persons with potential health hazards related to communicable diseases

771

2758

2.84

151.82

3.7

3.4

—

DVT of lower extremities and pulmonary embolism

934

3723

2.57

150.38

4.4

3.5

—

Biguanides

1767

5426

2.04

150.06

3.8

3.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

1906

5392

2.00

149.63

4.4

3.2

—

Psychiatric diseases

2026

5228

1.97

148.25

3.8

3.5

—

Oedema, not elsewhere classified

632

2066

3.13

147.62

4.8

3.3

—

Other and unspecified iron deficiency

735

2639

2.87

146.83

4.8

3.3

—

Other interstitial pulmonary diseases

456

1235

3.92

146.78

5.4

3.6

—

Syncope and collapse

866

2951

2.66

146.63

3.5

3.4

—

Hypertensive heart and/or renal disease

548

1232

3.56

146.53

5.7

3.0

—

Mood disorders, excluding more controls

1706

5145

2.05

146.37

3.8

3.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

621

882

3.58

145.88

3.7

3.0

—

Any mental disorder

2069

5410

1.94

145.76

3.8

3.5

—

910

3618

2.55

145.16

4.4

3.4

—

Interstitial lung disease

456

1246

3.88

144.91

5.4

3.7

—

Interstitial lung disease endpoints

456

1246

3.88

144.91

5.4

3.7

—

Disorders of lipoprotein metabolism and other lipidaemias

1502

4493

2.14

144.86

4.1

3.3

—

ILD, hospital admissions

450

1222

3.91

144.33

5.3

3.8

—

Sub-endpoint used in defining T1D endpoints

716

2511

2.89

144.29

5.5

3.6

—

Genitourinary diseases

1172

2444

2.44

144.28

4.7

2.6

—

Hydronephrosis

315

651

5.12

143.94

5.4

2.9

—

Symptoms and signs involving the digestive system and abdomen

1923

4937

1.98

143.04

3.8

3.5

—

Symptoms and signs involving the urinary system

1511

5709

2.08

142.68

4.1

3.6

—

Other disorders of urethra and urinary system

1317

4563

2.20

142.34

4.5

3.4

—

Diseases of the respiratory system

1114

2281

2.48

141.99

4.0

2.7

—

COPD, hospital admissions 1, only main diagnosis

856

2834

2.66

141.75

5.5

3.5

—

Coronary atherosclerosis

1325

3917

2.23

141.54

4.8

3.4

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

989

4169

2.43

141.49

3.8

3.7

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1277

5522

2.19

141.34

4.7

3.5

—

Ischemic heart diseases

1472

4408

2.13

140.34

4.6

3.4

—

Schizophrenia or delusion, excluding more controls

607

1989

3.11

140.30

3.8

3.4

—

Acute upper respiratory infections of multiple and unspecified sites

1408

5038

2.13

140.08

4.4

3.3

—

Heart failure and coronary heart disease

837

2377

2.72

139.96

5.4

3.6

—

Used for control exclusion in common control thyroid runs

1976

5247

1.93

138.44

4.1

3.2

—

Other diseases of urinary system

1920

5665

1.93

137.95

4.1

3.4

—

Disorders of mineral metabolism

262

482

5.83

137.09

5.0

3.6

—

Hernia of abdominal wall, postoperative

378

940

4.16

135.78

5.2

2.7

—

COPD-related respiratory insufficiency

369

909

4.32

135.73

8.6

3.7

—

Ischaemic heart disease, wide definition

1445

4354

2.12

135.38

4.6

3.4

—

Early onset COPD

553

1780

3.23

134.89

5.4

3.5

—

Other diseases of blood and blood-forming organs, wide

543

1730

3.27

134.80

4.5

3.7

—

Anxiety disorders, excluding more controls

1435

4595

2.10

134.70

4.0

3.4

—

Diseases of arteries, arterioles and capillaries

1345

4800

2.14

133.85

5.0

3.5

—

Hyperkalaemia

213

329

7.10

133.80

7.3

3.5

—

Abdominal and pelvic pain

1884

4936

1.94

133.66

3.7

3.5

—

Alcohol use disorder, ICD-based

914

3824

2.45

133.43

3.7

—

Adjustment and management of implanted device

479

1427

3.51

132.80

4.3

3.2

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

543

1755

3.22

131.59

3.3

3.7

—

Paroxysmal tachycardia

391

830

4.08

131.28

4.7

2.2

—

Headache

1041

3813

2.32

130.72

3.6

3.2

—

Viral pneumonia (unknown virus, not influenza)

237

416

6.15

130.61

6.7

3.6

—

Conduction disorders

598

1663

3.08

129.67

4.4

3.0

—

All influenza

527

1685

3.22

129.36

5.5

3.0

—

Disorders of lens

1291

3823

2.17

129.26

5.0

3.5

—

Chronic nephritic syndrome

188

269

7.85

127.46

8.3

3.2

—

Other general symptoms and signs

169

208

8.65

127.34

3.6

3.1

—

Suicide or other Intentional self-harm

546

1800

3.13

127.33

3.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

598

2074

2.96

127.17

3.4

—

Endocrine disorders, other/unspecified

126

111

13.46

124.85

3.4

2.6

—

Haemorrhage from respiratory passages

695

2430

2.72

124.20

4.8

3.4

—

Disorders of gallbladder, biliary tract and pancreas

1794

6239

1.88

122.23

4.0

3.5

—

Constipation

1617

6095

1.93

121.79

4.1

3.6

—

Complications of procedures, not elsewhere classified

1455

6483

1.97

120.75

4.3

3.4

—

Pain in limb

1477

5500

1.97

118.87

4.1

3.5

—

Adrenocortical insufficiency

150

183

9.13

116.29

5.2

3.5

—

Asthma (diagnoses ohter than nonallergic)

1573

7212

1.89

115.79

3.9

3.5

—

ILD, hospital admissions 1, main diag only

384

1091

3.73

115.26

5.4

3.8

—

Other reaction to severe stress, and adjustment disorders

665

2567

2.65

114.86

4.4

3.2

—

Other disorders of adrenal gland

173

252

7.53

114.84

5.3

3.3

—

Mood [affective] disorders

1806

6564

1.83

114.59

3.8

3.5

—

Mood disorders

1811

6578

1.83

114.59

3.8

3.5

—

STROKE

958

2929

2.31

114.20

4.1

3.0

—

Anaemia in chronic diseases classified elsewhere

134

147

10.66

113.85

8.8

3.3

—

Lung cancer and mesothelioma

390

932

3.70

113.67

3.9

2.9

—

Problems related to lifestyle

260

558

4.87

113.32

4.1

3.2

—

Diseases of the digestive system

946

4318

2.24

111.88

4.6

3.6

—

Hypothyroidism, drug reimbursement

213

240

6.48

111.73

4.1

2.0

—

Other soft tissue disorders, not elsewhere classified

1693

5703

1.86

110.63

3.8

3.5

—

Insulin, fast-acting (human)

353

969

3.78

110.59

5.5

3.2

—

Depression

1650

6204

1.85

109.80

3.6

3.5

—

Fall on same level

2041

6551

1.76

109.55

3.8

3.5

—

Abnormal spermatozoa

365

1047

3.71

108.34

4.1

—

Disorders of calcium metabolism

201

361

5.99

108.12

5.3

3.7

—

Retention of urine

752

2646

2.47

107.61

4.3

3.7

—

Hypertensive Renal Disease

138

168

9.00

106.81

7.8

3.1

—

Personality disorders

526

1878

2.87

106.11

3.7

3.4

—

Anxiety disorders

1519

5802

1.88

106.05

3.9

3.4

—

Complications of medical and surgical care

1310

6509

1.94

105.96

4.3

3.4

—

Substance use, excluding alcohol

422

1336

3.26

105.58

4.1

3.6

—

Neurotic, stress-related and somatoform disorders

1498

5727

1.88

105.34

3.9

3.5

—

Depression or dysthymia

1244

3444

2.05

105.20

3.6

3.5

—

Other retinal disorders

1205

4898

2.01

104.62

4.7

3.5

—

Senile cataract

1140

3445

2.09

103.46

4.6

3.5

—

Disorders of adult personality and behaviour

541

1991

2.78

102.98

3.4

—

Use of hypnotics and sedatives

1881

6240

1.76

102.45

3.8

3.5

—

Anxiety (asthma-related co-morbidities)

949

3485

2.18

101.81

3.2

3.4

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

481

1679

2.95

101.47

4.1

3.5

—

Diagnoses used for exclusion with ILD

574

2209

2.68

100.53

4.2

3.6

—

Abnormalities of heart beat

608

2379

2.58

100.12

3.4

3.3

—

Diseases of liver

684

2862

2.45

100.09

4.2

3.7

—

Injuries to the head

1905

7245

1.73

100.06

3.8

3.5

—

Other arrhythmias

996

3642

2.12

99.64

3.4

2.9

—

Selective serotonin reuptake inhibitors

1768

5256

1.79

99.21

3.4

3.5

—

Dental caries

552

2075

2.71

98.95

6.8

3.4

—

ILD medications: azathioprine

329

928

3.67

98.95

6.6

3.0

—

Exclusions for E4_PCOS_BROAD

393

1246

3.27

98.28

5.2

3.8

—

AV-block

371

1016

3.43

98.05

4.7

3.1

—

Kela-code for severe mental illness

701

2993

2.39

97.70

3.9

3.4

—

Infections of the skin and subcutaneous tissue

1040

5185

2.03

96.58

5.1

3.4

—

Other functional intestinal disorders

852

3769

2.20

96.03

4.1

3.6

—

Other diseases of the digestive system

690

2956

2.40

95.87

4.7

3.6

—

Asthma/COPD (KELA code 203)

1603

6392

1.79

95.48

4.2

3.3

—

Peripheral artery disease

900

3411

2.17

95.23

5.3

3.6

—

Lung diseases due to external agents

372

1168

3.33

95.04

4.7

3.9

—

Unspecified mental disorder

749

3333

2.29

94.63

3.9

3.5

—

Diseases of oesophagus, stomach and duodenum

1842

6556

1.73

94.25

3.9

3.5

—

Pacemaker

715

3043

2.35

94.10

4.6

3.7

—

Congenital malformations of the urinary system

191

372

5.51

94.08

8.1

3.9

—

Nephrotic syndrome

139

200

7.76

93.74

8.3

2.8

—

Myocardial infarction

951

3278

2.13

93.14

4.9

3.4

—

Morphin

12.17

92.52

8.2

4.3

—

Schizophrenia, schizotypal and delusional disorders

610

2509

2.49

92.50

3.9

3.5

—

Schizophrenia or delusion

607

2499

2.48

91.86

3.8

3.5

—

Disorders of choroid and retina

1434

5802

1.83

91.69

4.5

3.6

—

Diabetic retinopathy, excluding more controls

629

1394

2.64

91.68

5.4

3.2

—

GI-bleeding

685

2983

2.36

91.63

4.7

3.6

—

Symptoms and signs involving the nervous and musculoskeletal systems

1036

5289

1.99

91.08

3.9

3.6

—

Azathioprine

329

980

3.47

91.03

6.6

3.2

—

Fungal Sepsis

135

194

7.63

90.76

8.4

2.7

—

Implicit fungal Sepsis

127

172

8.13

90.07

8.5

2.7

—

Dentinal caries

488

1820

2.74

89.88

6.6

3.3

—

Cystic kidney disease

137

203

7.50

89.87

8.1

3.5

—

Other diseases of intestines

1810

6203

1.71

89.62

3.9

3.4

—

Osteopathies and chondropathies

970

4604

2.03

89.58

4.7

3.4

—

Later onset COPD

641

2107

2.47

89.55

5.0

3.3

—

Hard cardiovascular diseases

1351

4741

1.86

88.63

4.5

3.5

—

Other anxiety disorders

735

2934

2.26

88.10

3.2

—

Specific personality disorders

443

1605

2.83

87.06

3.5

—

Acute alcohol intoxication, ICD10

434

1559

2.87

87.05

3.7

3.8

—

Pain, not elsewhere classified

445

1617

2.81

86.75

3.8

3.3

—

Recurrent or chronic depression

634

1912

2.43

86.21

3.1

3.4

—

Other cataract

784

2803

2.21

86.20

5.0

3.4

—

Intracranial injury

1040

5227

1.95

86.10

3.6

—

Hypothyroidism, strict autoimmune

1228

4363

1.89

85.78

3.8

3.2

—

Hypertensive Heart Disease

415

1169

2.98

85.31

5.1

3.0

—

Disorders of parathyroid gland

435

1560

2.84

85.22

6.4

3.3

—

Other pleural conditions

262

705

3.90

85.07

5.3

3.2

—

Abnormal findings on diagnostic imaging of lung

892

4330

2.05

83.95

4.9

3.6

—

Unspecified haematuria

817

3352

2.13

83.77

4.4

3.7

—

Vocal cord dysfunction

218

471

4.40

83.53

4.8

2.9

—

Cardiomyopathy

347

1126

3.18

83.39

5.1

3.0

—

Explicit bacterial Sepsis

237

602

4.11

83.19

6.2

3.0

—

Cystitis

1407

4845

1.80

82.70

3.8

3.4

—

Care involving use of rehabilitation procedures

1018

5055

1.94

82.52

3.7

2.9

—

Bacterial pneumoniae

685

2734

2.26

81.99

5.5

2.9

—

All anxiety disorders

963

3950

1.99

81.70

3.2

3.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

745

3513

2.16

81.65

4.1

3.6

—

Asthma, including avohilmo

1985

7145

1.63

81.44

3.8

3.5

—

Acute upper respiratory infections

1744

6578

1.68

81.28

4.1

3.4

—

Epilepsy

561

2350

2.43

81.14

3.8

3.5

—

Other disorders involving the immune mechanism, not elsewhere classified

128

198

7.16

80.64

8.1

3.5

—

Emphysema

203

473

4.55

80.44

5.6

3.7

—

Alcohol dependence

555

2338

2.44

80.15

4.0

3.9

—

Myocardial infarction, without ST-elevation

806

3625

2.10

80.14

5.0

3.7

—

Falls/tendency to fall

1879

5726

1.66

79.86

3.8

3.5

—

Other endocrine disorders

169

325

5.34

79.74

3.8

4.0

—

Low back pain

1259

5424

1.81

79.51

3.7

3.5

—

Angina pectoris

1023

3611

1.94

78.11

4.3

3.4

—

Malignant neoplasm

1444

4936

1.76

78.08

3.7

3.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

820

3217

2.08

77.80

5.3

3.6

—

Malignant neoplasm, wide definition for exclusion

1421

4827

1.76

77.49

3.7

3.6

—

Autoimmune diseases related-to ILD

1391

7148

1.73

77.28

3.8

3.5

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1420

4827

1.76

77.24

3.7

3.6

—

Acidosis

102

10.26

77.21

7.7

3.0

—

Acute alcohol intoxication

525

2196

2.45

77.05

4.0

3.8

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1419

4829

1.76

76.91

3.7

3.6

—

Drug-induced adrenocortical insufficiency

10.52

76.22

5.8

3.3

—

Other diseases of pericardium

130

216

6.44

75.77

5.4

3.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1032

5599

1.86

74.61

4.3

3.4

—

Preparatory care for dialysis

151

295

5.58

74.58

9.4

4.0

—

Acute peritonitis

197

477

4.40

74.47

9.1

3.9

—

Gastrointestinal diseases

966

2452

1.99

74.39

3.9

2.8

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

186

430

4.54

74.23

3.5

3.3

—

Certain disorders involving the immune mechanism

395

1470

2.77

74.14

5.1

3.7

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

118

185

7.06

73.41

8.4

3.4

—

IgA nephropathy (IgA glomerulonephritis)

106

150

7.92

72.68

8.8

3.2

—

Viral hepatitis, IBD co-morbidity

104

142

7.58

72.26

4.2

2.7

—

Paralytic ileus and intestinal obstruction

506

2142

2.42

72.25

4.1

3.5

—

Alcohol abuse, main dg, excluding more controls

296

953

3.20

72.17

4.0

3.8

—

Sequelae of external causes of morbidity and mortality

492

2067

2.44

71.64

4.4

3.6

—

Sequelae with surgical and medical care as external cause

413

1609

2.65

70.85

4.4

3.7

—

Spondylosis

944

4331

1.90

70.53

3.4

3.7

—

Other or unspecified ileus, impaction or obstruction

391

1485

2.71

70.45

4.1

3.5

—

Major coronary heart disease event excluding revascularizations

1150

4470

1.80

69.95

4.6

3.6

—

Pneumonia due to other infectious organisms, not elsewhere classified

109

165

7.17

69.79

5.9

3.6

—

Ulcer of lower limb, not elsewhere classified

320

1107

3.01

69.24

6.6

3.8

—

Secondary right heart disease

136

260

5.65

68.64

6.8

3.7

—

Cardiomyopathies, Primary/intrinsic

256

780

3.40

68.54

4.7

3.0

—

Other pulmonary heart/vessel disease

147

302

5.24

68.32

6.6

4.0

—

Cholelithiasis, broad definition with cholecystitis

1397

5731

1.69

67.99

3.7

3.5

—

Cardiomyopathy (excluding other)

262

815

3.33

67.82

4.6

3.1

—

Osteoporosis

479

1937

2.42

67.70

4.6

3.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1573

6818

1.63

67.68

3.6

—

Iron deficiency anaemia secondary to blood loss (chronic)

339

1226

2.86

67.35

5.2

3.5

—

Other disorders of bladder

281

918

3.19

67.27

4.0

3.9

—

Other and unspecified nonorganic psychotic disorders

359

1336

2.75

67.18

3.6

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

347

1274

2.81

66.98

3.0

3.6

—

Asthma, hospital admissions , main diagnosis only

1344

7249

1.68

66.94

3.8

3.5

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1499

6045

1.65

66.91

3.8

3.4

—

Hypothyroidism, other/unspecified

1458

5847

1.66

66.56

3.8

3.5

—

Cough

613

2776

2.15

66.46

3.7

3.4

—

Non-allergic asthma (mode), excluding more controls

276

883

3.16

66.44

4.8

2.5

—

Chronic periapical parodontitis

412

1652

2.56

66.42

6.7

3.4

—

Persons encountering health services for specific procedures, not carried out

177

433

4.27

65.57

4.2

2.8

—

Hyperparathyroidism

365

1372

2.71

65.51

7.0

3.2

—

Emotionally unstable personality disorder

236

702

3.46

65.51

3.7

3.0

—

Noninfective enteritis and colitis

784

4075

1.95

65.40

3.7

—

Diseases of pulp and periapical tissues

622

2985

2.12

65.28

6.0

3.4

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

112

186

6.41

65.26

6.4

2.8

—

Streptococcal septicaemia

200

537

3.90

65.20

6.6

3.7

—

Primary_lymphoid and hematopoietic malignant neoplasms

440

1839

2.45

64.75

4.4

3.7

—

Any event in cancer register

1440

5189

1.66

64.26

3.5

3.6

—

Other/unspecified cytomegaloviral diseases

102

9.18

64.23

9.9

2.7

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

204

563

3.81

64.07

5.1

3.8

—

External causes of morbidity and mortality

1102

3077

1.81

64.00

3.7

3.4

—

Finngen Rheumatological endpoints

1567

5539

1.63

63.95

3.9

3.3

—

Drug-induced neutropenia

183

471

4.10

63.57

3.6

3.8

—

Disorders of thyroid, IBD co-morbidities

242

511

3.51

63.54

3.2

2.7

—

Spondylopathies

1340

4876

1.69

63.51

3.5

3.6

—

Mental and behavioural disorders due to opioids

113

196

6.14

63.04

4.7

2.9

—

Other external causes of accidental injury

1380

4131

1.69

62.96

3.7

3.4

—

Major coronary heart disease event

1198

4693

1.73

62.58

4.7

3.6

—

Cholelithiasis

1325

5617

1.67

62.47

3.7

3.5

—

Myocardial infarction, strict

814

3123

1.93

62.32

4.8

3.5

—

Diseases of peritoneum

243

764

3.32

62.12

8.0

3.8

—

Cardiodefibrillation

692

3519

2.01

61.95

4.3

3.8

—

Undetermined asthma, excluding more controls

192

516

3.81

61.87

3.9

2.5

—

Intestinal stricture

568

2697

2.15

61.57

4.2

3.6

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

329

1183

2.77

61.56

6.3

3.8

—

Diseases of the skin and subcutaneous tissue

1697

5397

1.59

61.32

4.1

3.2

—

Dorsalgia

1646

5637

1.60

61.31

3.5

—

Diabetic retinopathy, strict definition

479

1863

2.36

61.23

5.9

3.8

—

Diseases of the myoneural junction and muscle

271

920

3.06

60.71

4.3

3.9

—

Idiopathic pulmonary fibrosis

210

615

3.61

60.52

6.0

3.9

—

Fluid overload

53.43

60.48

12.4

2.2

—

Accidents

1368

4131

1.67

60.44

3.8

3.4

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

543

2552

2.17

60.34

4.1

3.5

—

Pneumocystosis

9.66

59.87

6.2

2.9

—

Bacterial pneumonia (organism specified)

786

3824

1.90

59.76

5.5

3.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

934

5291

1.79

59.34

4.4

3.5

—

Abnormal results of function studies

199

568

3.66

59.30

4.7

3.7

—

Coagulation defects, purpura and other haemorrhagic conditions

369

1490

2.54

58.72

4.8

3.7

—

Agranulocytosis

241

780

3.21

58.65

4.2

3.6

—

Diseases of pulp and periapical tissues, including avohilmo

1752

5889

1.56

58.58

3.5

—

Disorders of the thyroid gland

1529

6340

1.59

58.51

3.8

3.5

—

Symptoms and signs concerning food and fluid intake

198

566

3.61

58.47

4.8

3.4

—

Non-invasive ventilation

264

835

3.02

58.38

12.0

2.7

—

Cytomegalovirus infection, IBD co-morbidity

126

7.65

58.33

9.5

2.8

—

Dysphagia

415

1778

2.39

57.76

5.0

3.6

—

Dental pulpitis 1

1748

5900

1.55

57.43

3.5

—

Cutaneous abscess, furuncle and carbuncle

446

1977

2.30

57.34

5.4

3.5

—

Dental pulpitis 4

1747

5900

1.55

57.20

3.5

—

Delirium, not induced by alcohol and other psychoactive substances

265

921

2.99

56.86

4.7

3.9

—

Acute pancreatitis

371

1525

2.50

56.80

4.5

3.8

—

Pain (limb, back, neck, head abdominally)

1227

3662

1.69

56.74

3.7

3.5

—

Second line medication for Crohn's disease

886

5009

1.79

56.73

4.7

3.5

—

L04AX Other immunosuppressants

867

4875

1.80

56.56

4.7

3.5

—

Emotional disorders starting during childhood or adolecense, excluding more controls

102

172

6.04

56.53

4.1

3.1

—

Bacterial pneumonia, not elsewhere classified

594

2598

2.05

56.30

5.5

2.8

—

Other disorders of skin and subcutaneous tissue

1092

5989

1.69

56.15

4.9

3.5

—

Viral and other specified intestinal infections

360

1428

2.51

56.01

5.5

3.1

—

Other noninfective gastroenteritis and colitis

442

1975

2.29

55.67

3.8

3.7

—

Pure hypercholesterolaemia

1069

4220

1.72

55.36

3.9

3.4

—

Mental and behavioural disorders due to sedatives or hypnotics

159

409

4.06

55.12

4.5

3.5

—

Cytomegaloviral disease

134

7.15

55.05

9.5

2.8

—

Open wound of head

875

4898

1.78

54.99

4.0

3.6

—

Failure and rejection of transplanted organs and tissues

10.60

54.91

10.2

2.9

—

Pneumonitis due to solids and liquids

205

628

3.42

54.84

4.9

3.8

—

Acute sinusitis

766

3889

1.86

54.83

4.0

3.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1305

5543

1.62

54.45

3.8

3.4

—

Non-allergic asthma (mode)

276

989

2.81

54.35

4.8

2.7

—

Purpura and other haemorrhagic conditions

276

1007

2.83

54.09

4.3

3.8

—

Abnormal findings on examination of urine, without diagnosis

129

289

4.76

53.99

6.0

3.9

—

Other obstructive and reflux uropathy

110

215

5.38

53.83

5.0

2.5

—

Neoplasms

1190

3840

1.68

53.78

3.8

3.4

—

Enlarged lymph nodes

258

909

2.90

53.65

3.4

3.3

—

Other disorders of glucose regulation and pancreatic internal secretion

197

597

3.44

53.50

5.6

3.8

—

Undetermined asthma

192

571

3.44

53.18

3.9

2.7

—

Thrombocytopenia, unspecified

177

504

3.69

53.16

4.6

4.0

—

Hypotension

345

1420

2.51

52.92

4.3

3.8

—

Chronic tubulo-interstitial nephritis

162

6.11

52.66

7.0

2.4

—

Cellulitis

390

1696

2.35

52.60

5.6

3.5

—

Dependence on enabling machines and devices, not elsewhere classified

12.73

52.55

10.1

2.8

—

Other CVD

385

1671

2.37

52.34

4.3

3.7

—

Other and unspecified myopathies

202

632

3.34

52.23

3.9

—

Peripheral arterial reconstruction

355

1491

2.46

52.11

5.8

3.8

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

244

852

2.97

51.97

4.4

3.8

—

ILD-related respiratory insufficiency

111

228

5.31

51.94

9.9

3.9

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1513

6423

1.55

51.43

4.3

3.5

—

Dermatitis

950

5631

1.71

51.43

4.5

3.5

—

Factors influencing health status and contact with health services

536

1255

2.17

51.38

4.3

2.7

—

Other specified and unspecified personality disorders

189

574

3.41

51.02

4.3

3.4

—

Other diseases of liver

325

1323

2.52

50.92

4.4

3.7

—

Cerebrovascular diseases

1193

5313

1.63

50.87

4.1

3.7

—

Chronic pancreatitis

252

906

2.88

50.85

4.7

3.8

—

Statin medication

1049

3489

1.70

50.75

4.4

3.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

297

1163

2.64

50.70

4.1

4.0

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

130

309

4.47

50.48

5.6

3.6

—

Respiratory conditions due to other external agents

115

7.41

50.22

4.0

3.3

—

Other disorders of teeth and supporting structures

386

1706

2.31

50.13

5.1

3.4

—

Ascites

161

448

3.75

49.93

4.1

—

Other viral diseases

470

2245

2.12

49.70

5.8

3.4

—

Diseases of the eye and adnexa

1284

4022

1.61

49.26

4.0

3.2

—

Lower back pain or/and sciatica

1587

7337

1.51

49.26

3.6

3.5

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

305

1102

2.57

49.14

3.3

—

Mixed and other personality disorders

166

478

3.60

48.75

4.0

3.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

138

350

4.09

48.68

4.9

2.5

—

All influenza (not pneumonia)

253

931

2.78

48.54

5.4

3.1

—

Sulfonylureas

637

2700

1.92

48.40

4.4

3.7

—

Primary_lymphoid and hematopoietic malignant neoplasms

440

2086

2.16

48.12

4.4

3.8

—

Status epilepticus

101

203

5.28

48.07

6.0

3.5

—

Schizophrenia

293

1167

2.57

48.03

4.4

3.7

—

Any operation in hilmo

17.14

47.90

2.5

1.8

—

Type of accident

479

2346

2.08

47.87

4.2

3.5

—

Other and unspecified effects of external causes

437

2067

2.15

47.84

4.0

3.5

—

Injuries to the thorax

747

4230

1.79

47.82

4.0

3.6

—

Unspecified fall

790

4509

1.76

47.75

3.9

3.7

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

433

1693

2.19

47.74

4.0

3.7

—

Other neurological diseases

1144

5779

1.61

47.63

3.8

3.6

—

Congenital malformations, deformations and chromosomal abnormalities

863

4869

1.72

47.50

5.0

3.2

—

Other arthritis (FG)

494

2458

2.04

47.18

4.6

3.4

—

Gastroduodenal ulcer

492

2443

2.05

47.08

4.6

3.6

—

Stroke, including SAH

1027

4651

1.65

47.01

4.1

3.7

—

Acute pancreatitis (for exclusion)

371

1659

2.29

46.98

4.5

3.8

—

Alcohol abuse, main dg

296

1200

2.53

46.84

4.0

3.9

—

Isolated proteinuria with specified morphological lesion

10.49

46.79

8.0

2.7

—

Stroke, excluding SAH

988

4460

1.67

46.59

3.9

3.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

485

2406

2.05

46.57

3.6

3.4

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

255

964

2.73

46.50

3.6

3.8

—

Presbycusis

300

1225

2.51

46.35

3.7

—

Cardiac arrest

111

205

4.81

46.20

5.0

1.9

—

Bipolar affective disorders

292

1183

2.52

46.04

3.7

3.3

—

Dental pulpitis 1, only avohilmo

1735

6167

1.48

45.93

3.3

3.6

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

211

730

2.99

45.79

4.5

3.9

—

KRA_PSY_EATING, excluding more controls

124

302

4.19

45.76

3.3

2.5

—

Calcific aortic valvular stenosis

555

2847

1.95

45.72

4.4

3.7

—

Calcific aortic valvular stenosis, operated

555

2847

1.95

45.72

4.4

3.7

—

Calcific aortic valvular stenosis, including rheumatic fever

556

2852

1.95

45.68

4.4

3.7

—

Operations 2 for CAVS

554

2845

1.95

45.48

4.4

3.7

—

Calcific aortic valvular stenosis, diagnosis (helper)

554

2845

1.95

45.48

4.4

3.7

—

Non-selective monoamine reuptake inhibitors

579

2988

1.91

45.14

4.2

3.4

—

Isolated proteinuria

178

5.50

44.87

6.3

3.0

—

Viral infections characterized by skin and mucous membrane lesions

649

3591

1.83

44.82

5.2

3.5

—

Deposits [accretions] on teeth

157

443

3.56

44.81

11.5

3.7

—

Dental pulpitis 4, only avohilmo

1725

6160

1.47

44.60

3.3

3.6

—

Endocarditis

172

5.47

44.25

6.4

2.9

—

Systemic connective tissue disorders

554

2938

1.92

43.99

4.0

3.5

—

Other infectious diseases

180

583

3.21

43.96

5.3

3.9

—

Motor neuron disease (with DMD)

8.00

43.91

5.7

4.1

—

Suppurative and necrotic conditions of lower respiratory tract

145

412

3.71

43.88

6.3

4.0

—

Other bacterial intestinal infections

326

1421

2.35

43.88

5.7

3.3

—

Other disorders of white blood cells

135

366

3.88

43.68

5.1

3.9

—

Secondary polycythaemia

150

5.96

43.65

3.9

3.8

—

Artificial opening status

124

318

4.10

43.38

5.5

3.7

—

Aortic aneurysm

433

2084

2.09

43.35

4.1

3.6

—

Other specified/unspecified arthritis

435

2133

2.07

43.34

4.6

3.5

—

Other/unspecified dorsalgia

591

3202

1.86

43.06

3.7

3.6

—

Nonorganic sleeping disorders, excluding more controls

263

1048

2.56

42.98

3.5

3.4

—

Obesity, other/unspecified

470

2381

2.00

42.65

3.9

3.2

—

Vitreous haemorrhage

215

782

2.85

42.63

5.8

3.8

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

658

2862

1.82

42.58

3.6

3.7

—

Diabetic retinopathy

743

2691

1.79

42.57

5.2

4.0

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

381

1478

2.20

42.31

4.0

3.6

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

146

425

3.57

42.31

4.3

3.8

—

Motor neuron disease

8.09

42.21

5.5

4.0

—

Other metabolic disorders

207

739

2.87

42.18

3.7

3.2

—

Protozoal diseases

162

5.59

42.12

6.2

4.0

—

Eosinophilic disease (BM)

10.22

42.12

5.6

2.9

—

Disorders of magnesium metabolism

14.91

42.02

4.0

2.4

—

Gastro-oesophageal reflux disease

1026

5754

1.60

42.02

3.7

3.6

—

Ischaemic Stroke, excluding all haemorrhages

922

4282

1.65

41.84

3.9

3.8

—

Arthropathies in other diseases classified elsewhere

100

225

4.71

41.67

7.0

3.5

—

Enterocolitis due to Clostridium difficile

221

829

2.75

41.22

6.0

3.7

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

624

3479

1.81

41.21

3.9

3.6

—

Pleural plaque

211

775

2.83

41.11

4.0

3.3

—

Gout due to impairment of renal function

9.93

40.68

7.6

2.7

—

Other and unspecified dermatitis

759

4523

1.70

40.47

4.6

3.4

—

Type 1 diabetes, definitions combined

172

567

3.10

40.25

3.6

3.5

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

113

289

4.14

39.84

3.8

3.7

—

Soft tissue disorders

1618

5804

1.46

39.84

3.5

—

Diseases of the musculoskeletal system and connective tissue

858

2566

1.69

39.82

4.0

3.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

252

1027

2.52

39.53

3.8

3.6

—

Hyperkinetic disorders, excluding more controls

137

386

3.52

39.43

3.2

3.1

—

Other dorsopathies, not elsewhere classified

1560

5662

1.46

39.32

3.5

—

Hypoglycaemia, other or unspecified

150

466

3.35

39.28

4.9

3.9

—

Migraine

574

2690

1.83

39.09

3.0

3.4

—

Combinations of oral blood glucose lowering drugs

437

2230

1.99

39.06

3.5

3.7

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

177

609

3.02

38.98

5.5

3.8

—

Type 1 diabetes, strict (exclude DM2)

171

574

3.04

38.80

3.6

—

Bacterial intestinal infections, IBD co-morbidities

322

1476

2.23

38.47

5.7

3.7

—

Other diseases of blood and blood-forming organs

151

483

3.26

37.77

4.4

3.9

—

Injury, poisoning and certain other consequences of external causes

829

2494

1.68

37.52

3.7

3.4

—

Valvular operations

229

918

2.55

37.16

5.4

3.1

—

Focal epilepsy

357

1726

2.11

37.11

3.7

—

Fibrosis and cirrhosis of liver

155

510

3.16

36.94

4.1

4.2

—

Elevated blood glucose level

173

606

2.96

36.85

5.7

4.0

—

Other symptoms and signs involving the digestive system and abdomen

241

993

2.47

36.79

4.3

3.5

—

Benign neoplasms

1096

4033

1.55

36.77

3.8

3.4

—

Hernia of abdominal wall

705

4237

1.69

36.57

4.6

3.6

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

171

598

2.95

36.46

4.3

3.6

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

276

1140

2.34

36.41

3.9

3.7

—

Cirrhosis of liver, NAS

121

346

3.68

36.33

3.9

4.4

—

Peripheral artery operations in Hilmo

248

1044

2.44

36.29

6.8

3.6

—

Dizziness and giddiness

1104

5943

1.52

36.29

3.5

3.6

—

127

5.76

36.27

3.1

3.2

—

Other systemic involvement of connective tissue (FG)

388

1936

2.02

36.20

3.6

3.3

—

Charcot foot

6.94

36.04

9.7

3.3

—

Other sleep disorders

189

701

2.77

35.96

3.6

—

Noninfectious colitis NAS

238

988

2.47

35.91

4.0

3.7

—

Pyothorax

115

321

3.79

35.88

6.6

4.0

—

Other and unspecified drugs and medicaments

164

570

2.98

35.42

4.0

3.7

—

Nerve, nerve root and plexus disorders

1573

6993

1.42

35.37

3.6

—

Cerebral cysts

125

372

3.50

35.14

3.8

3.6

—

Other complications of surgical and medical care, not elsewhere classified

175

635

2.84

34.81

4.5

3.4

—

Malnutrition

122

5.87

34.77

4.8

4.0

—

Amputation

204

804

2.62

34.54

7.2

4.0

—

Alcoholic liver disease

199

777

2.65

34.40

4.3

4.0

—

Osteoporosis with pathological fracture (FG)

132

412

3.33

34.36

4.4

2.9

—

Postviral fatigue syndrome

12.68

34.20

1.3

1.5

—

Post-traumatic stress disorder

128

392

3.35

34.13

3.1

2.8

—

Emotional disorders and disorders of social functioning with onset specific to childhood

107

288

3.79

34.07

4.0

3.3

—

Traumatic subdural haemorrhage

221

894

2.49

33.90

4.3

3.5

—

Dissociative [conversion] disorders

181

4.66

33.89

2.8

2.5

—

Duodenal ulcer

219

901

2.50

33.82

4.9

3.8

—

Fracture of rib(s), sternum and thoracic spine

477

2632

1.84

33.63

3.8

3.7

—

Intestinal malabsorption

260

3.98

33.55

4.2

3.3

—

Attention to artificial openings

243

4.12

33.50

6.3

3.0

—

Alcohol-induced chronic pancreatitis

145

487

3.10

33.43

4.4

4.0

—

Acute and transient psychotic disorders

201

798

2.58

33.39

4.1

3.7

—

Polyneuropathies and other disorders of the peripheral nervous system

368

1873

2.01

33.36

5.6

3.8

—

Collagenous colitis

165

595

2.86

33.30

3.9

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

145

5.15

33.20

3.7

2.9

—

Other specified disorders of kidney and ureter

206

4.42

33.16

7.2

3.3

—

Mouth breathing

615

3658

1.70

33.13

3.7

3.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

380

1932

1.97

33.12

4.3

3.3

—

Exclusions for E4_PCOS_CONSORTIUM

955

3888

1.55

33.03

3.6

3.3

—

Injuries to the ankle and foot

949

5686

1.53

33.02

3.7

3.5

—

Other headache syndromes

521

2963

1.78

32.94

3.5

3.4

—

Phlebitis and thrombophlebitis (not including DVT)

349

1752

2.03

32.81

4.6

3.5

—

Neuromuscular dysfunction of bladder

164

594

2.84

32.79

4.8

3.7

—

Diverticular disease of intestine

1041

4605

1.51

32.51

4.0

3.6

—

Clear cell adenocarcinoma of kidney

113

333

3.58

32.50

3.8

4.0

—

Cardiomyopathy, other and unspecified

139

464

3.09

32.22

5.9

3.0

—

Schizoaffective disorder

141

475

3.06

32.17

3.9

3.5

—

Type 1 diabetes, strict definition, subgroup 1

127

401

3.24

32.11

3.4

—

Reimbursement for rheumatic diseases

817

5247

1.57

31.87

3.9

3.5

—

Idiopathic gout

190

756

2.60

31.71

5.7

3.8

—

Hypoparathyroidism

213

4.26

31.71

4.0

3.3

—

Inflammatory bowel disease

467

2607

1.82

31.61

3.4

3.5

—

Ventral hernia

389

2056

1.93

31.50

4.8

3.6

—

Haemorrhage, not elsewhere classified

172

4.62

31.37

5.7

3.2

—

Other hearing loss

458

2507

1.82

31.29

4.0

3.7

—

Unspecified contracted kidney

12.54

31.27

10.0

2.8

—

Other and unspecified tonsillitis

443

2053

1.85

31.21

3.5

3.2

—

Pneumonia due to Streptococcus pneumoniae

228

4.06

31.21

5.2

3.4

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

221

947

2.39

31.16

3.9

3.7

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

6.88

31.16

4.9

2.4

—

Focal epilepsy, strict definition

323

1608

2.05

31.13

3.6

3.8

—

Type 1 diabetes, strict definition

132

435

3.10

31.04

3.7

3.4

—

Coronary revascularization (ANGIO or CABG)

694

2981

1.64

30.94

4.8

3.5

—

Dental caries 1 and operation codes

1320

4730

1.44

30.73

3.8

3.6

—

Hypoplasia of dental enamel, including avohilmo

9.12

30.63

15.3

5.5

—

Hypopituitarism

135

457

3.05

30.61

5.0

3.7

—

Malignant neoplasm of urinary organs

196

805

2.51

30.54

4.6

4.0

—

Drug-induced hypoglycaemia without coma

6.73

30.45

7.1

3.9

—

Myocarditis

155

4.70

30.43

5.7

1.9

—

Mental and behavioural disorders due to cannabinoids

156

4.76

30.42

3.2

3.0

—

Fentanyl

175

681

2.63

30.32

4.8

3.6

—

Other blood glucose lowering drugs, excl. Insulins

267

1252

2.18

30.25

4.9

3.6

—

Other diseases of biliary tract

159

592

2.77

30.24

4.7

3.7

—

Abnormal findings on examination of blood, without diagnosis

745

4444

1.59

30.24

4.7

3.7

—

Vascular disorders of the intestines

142

499

2.95

30.18

4.0

3.7

—

Disorders of refraction and accommodation

374

1969

1.92

30.18

4.4

3.5

—

Ulcerative ileocolitis

239

3.93

30.05

2.9

3.7

—

Emotional disorders starting during childhood or adolescence

102

292

3.59

29.99

4.1

3.6

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

8.86

29.60

7.5

2.2

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

7.83

29.28

5.8

2.4

—

Other and unspecified polyneuropathies, also in other diseases

318

1612

2.01

29.26

6.0

3.7

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

737

3835

1.58

29.10

4.0

3.2

—

Dental pulpitis 2

1077

3745

1.48

29.06

3.7

3.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

169

663

2.60

28.79

3.8

3.0

—

Diseases of the ear and mastoid process

1723

6445

1.36

28.69

3.8

3.5

—

Other gastritis (incl. Duodenitis)

362

1928

1.91

28.67

4.3

3.6

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

302

1514

2.03

28.60

3.7

3.8

—

Eosinophilia

6.44

28.58

5.6

3.7

—

Dorsopathies

1538

5704

1.38

28.55

3.5

—

Mycoses

392

2146

1.85

28.44

5.6

3.6

—

Other diseases of pancreas

142

516

2.84

28.37

4.6

3.8

—

Drug-induced osteoporosis with pathological fracture

6.43

28.31

4.9

4.1

—

Carrier of infectious disease

122

5.20

28.30

5.9

3.0

—

Internal derangement of knee

548

3292

1.68

28.26

4.0

3.5

—

Phobic anxiety disorders

182

748

2.47

28.03

2.9

3.1

—

Cholecystectomy

982

5950

1.47

27.96

3.6

—

Cholangitis (primary sclerosing, PSC)

121

406

3.09

27.96

4.9

3.6

—

Molar incisor enamel hypoplasia, with caries

9.27

27.92

15.1

2.5

—

Multiple myeloma and malignant plasma cell neoplasms

100

300

3.48

27.92

4.1

3.8

—

Crohn disease

209

918

2.32

27.83

2.8

3.8

—

Benign neoplasm of colon, rectum, anus and anal canal

720

3281

1.58

27.82

4.3

3.6

—

Malignant neoplasm of kidney, except renal pelvis

179

737

2.51

27.80

4.5

4.1

—

Dental caries 3 and operation codes

1352

4957

1.41

27.80

3.8

3.6

—

Dental pulpitis 2, only avohilmo

1096

3857

1.46

27.79

3.6

—

Other embolism and thrombosis

213

945

2.30

27.74

4.7

3.6

—

L01XE Protein kinase inhibitors

118

394

3.12

27.60

4.8

4.0

—

Other diseases of oesophagus

179

739

2.49

27.54

3.8

3.7

—

Symptoms and signs involving appearance and behaviour

8.89

27.43

4.3

2.0

—

Other degenerative diseases of the nervous system

369

1496

1.89

27.39

3.4

—

Open wound of lower leg

235

1092

2.20

27.31

4.6

3.8

—

Pericarditis

183

4.21

27.28

6.5

2.9

—

Intentional self-harm by sharp object

122

5.07

27.23

3.0

2.0

—

In situ neoplasms

454

2501

1.75

27.20

4.5

3.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

630

3933

1.60

27.15

4.2

3.4

—

Osteomyelitis

132

473

2.89

27.15

7.1

4.2

—

Sensorineural hearing loss

1109

5438

1.44

27.13

3.8

3.7

—

Benign intracranial hypertension

9.29

27.08

3.4

1.8

—

Nonalcoholic fatty liver disease

152

585

2.67

27.07

3.5

3.7

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

301

3.43

27.07

4.2

3.8

—

Other viral diseases, not elsewhere classified

279

1384

2.04

27.00

6.3

3.6

—

Dermatitis and eczema

1560

7583

1.36

26.82

4.2

3.4

—

Sleep disorders

309

1597

1.96

26.79

3.7

3.5

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

197

861

2.35

26.67

4.5

3.8

—

Other and unspecified vasculitis limited to skin

137

4.81

26.57

6.1

3.6

—

Injuries to the hip and thigh

696

4119

1.56

26.47

3.7

3.6

—

Hernia

1334

6567

1.39

26.43

4.0

3.6

—

Gastric ulcer

300

1544

1.98

26.43

4.4

3.7

—

Use of disulfiram, acamprosate or naltrexone

155

611

2.61

26.33

3.5

4.0

—

Migraine without aura

216

982

2.23

26.32

3.1

—

Leisure time condition

279

1405

2.02

26.16

4.2

3.7

—

Pneumonia due to Haemophilus influenzae

17.58

26.08

5.9

2.4

—

Arthropathies

1324

4853

1.40

25.97

3.9

3.4

—

Superficial injury of lower leg

348

1891

1.87

25.88

4.1

3.5

—

Ill-defined and unknown causes of mortality

149

583

2.65

25.87

5.2

4.0

—

Other and unspecified disorders of white blood cells

256

3.59

25.80

4.7

3.7

—

Simple and mucopurulent chronic bronchitis

261

3.54

25.68

5.7

4.2

—

Candidiasis

206

933

2.25

25.55

6.0

3.4

—

Acute pharyngitis

205

918

2.25

25.55

3.3

—

Other ill-defined and unspecified causes of mortality

136

512

2.76

25.55

5.1

4.0

—

Amputation of toe

146

570

2.65

25.46

7.4

3.8

—

Abdominal aortic aneurysm (AAA)

203

909

2.27

25.43

4.5

3.8

—

Unspecified nephritic syndrome

138

4.70

25.41

7.7

3.1

—

Arterial embolism and thrombosis

121

430

2.91

25.25

5.4

3.7

—

Infective dermatitis

195

870

2.29

25.14

4.7

3.6

—

Ulcerative colitis

354

1956

1.83

24.96

3.6

3.7

—

Unspecified acute lower respiratory infection

228

1085

2.14

24.95

5.5

3.5

—

Other systemic involvement of connective tissue

395

2256

1.78

24.93

3.6

3.5

—

Non-follicular lymphoma, hilmo, excluding all cancers

157

640

2.52

24.89

3.9

—

Vasculitis limited to skin, not elsewhere classified

149

4.47

24.78

6.0

3.5

—

Non-small cell lung cancer

276

1414

1.99

24.75

3.9

—

Dental caries, including avohilmo

1166

4239

1.42

24.73

3.7

3.6

—

Dental caries 1

1167

4244

1.41

24.68

3.7

3.6

—

Other joint disorders

1256

4835

1.39

24.41

3.3

—

Injuries to the knee and lower leg

1692

7346

1.33

24.39

3.8

3.5

—

Mental retardation, excluding more controls

195

3.87

24.28

4.8

4.7

—

Assault

196

890

2.24

24.15

4.3

3.5

—

Conductive and sensorineural hearing loss

1138

5663

1.40

24.13

3.8

3.7

—

Crohn's disease NAS

115

408

2.90

24.04

3.0

3.8

—

Benign neoplasm of other and unspecified endocrine glands

181

798

2.31

23.98

3.8

3.6

—

Personal history of certain other diseases

6.03

23.92

3.9

1.9

—

Other symptoms and signs involving the circulatory and respiratory systems

105

355

3.04

23.90

4.5

3.5

—

Organic, including symptomatic, mental disorders

748

3601

1.52

23.87

3.7

—

Abnormalities of gait and mobility

205

956

2.20

23.79

3.6

4.2

—

Benign neoplasms

1457

6058

1.35

23.72

3.9

3.4

—

Other disorders of ear

1295

6345

1.37

23.65

3.8

3.7

—

Presence of cardiac and vascular implants and grafts

627

3056

1.57

23.64

4.2

3.5

—

Adverse effects, not elsewhere classified

276

1435

1.95

23.60

4.0

3.4

—

Alcohol withdrawal state with delirium

139

552

2.60

23.41

3.6

4.1

—

Dental caries 3

1219

4509

1.39

23.39

3.8

3.7

—

Childhood asthma (age<16), excluding more controls

148

466

2.55

23.35

3.5

2.4

—

Benign neoplasm: Colon

623

3080

1.56

23.33

4.2

3.7

—

Ulcerative colitis, NAS

212

1011

2.14

23.12

3.8

—

Protein-energy malnutrition of moderate and mild degree

7.23

22.78

5.0

4.6

—

Malignant neoplasm of bladder

150

626

2.47

22.74

4.0

4.1

—

446

2385

1.68

22.67

3.8

3.7

—

Bronchiectasis

132

519

2.61

22.63

5.5

3.5

—

Use of pramipexole

322

1788

1.83

22.49

3.9

3.6

—

Pneumothorax

122

463

2.71

22.47

5.7

3.4

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

436

2634

1.67

22.42

4.0

3.6

—

Panic disorder

186

852

2.21

22.40

3.3

3.2

—

Fibromyalgia

115

423

2.77

22.39

3.2

3.0

—

Chronic viral hepatitis

321

3.08

22.37

4.3

3.2

—

Other diseases of intestine

194

907

2.18

22.34

4.7

3.7

—

Maltreatment syndromes

295

3.17

22.34

3.5

2.8

—

Childhood asthma (age<16)

148

477

2.49

22.29

3.5

2.6

—

Rheumatoid arthritis

445

2451

1.67

22.28

3.9

3.5

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

115

426

2.79

22.27

3.8

3.9

—

Fracture of foot, except ankle

325

1815

1.81

22.19

4.1

3.7

—

Meniscus derangement

796

3726

1.47

22.14

3.5

—

Multiple myeloma and malignant plasma cell neoplasms

100

346

3.01

22.09

4.1

4.0

—

Temporomandibular joint disorders

193

903

2.16

22.02

2.9

3.5

—

Other condition

210

1018

2.10

21.98

4.1

3.8

—

Immunodeficiencies

283

3.22

21.96

5.7

3.8

—

Zoster [herpes zoster]

267

1412

1.92

21.80

5.2

3.6

—

Nonorganic sleeping disorders

263

1387

1.92

21.60

3.5

—

Eating disorder

124

483

2.61

21.51

3.3

2.7

—

Sulfasalazine

355

2056

1.74

21.34

3.8

3.1

—

Pyogenic arthritis

117

447

2.69

21.27

5.6

3.4

—

Misadventures to patients during surgical and medical care

208

1018

2.08

21.24

5.0

3.5

—

Dental caries 1, only avohilmo

1178

4408

1.37

21.20

3.6

3.8

—

Degeneration of macula and posterior pole

669

3706

1.50

21.13

3.8

3.6

—

Coronary angioplasty

534

2617

1.58

21.10

4.4

3.5

—

Dental caries 3, only avohilmo

1233

4655

1.36

20.99

3.7

—

Fracture of shoulder and upper arm

498

3159

1.59

20.97

4.1

3.7

—

Abnormal findings on diagnostic imaging of other body structures

187

884

2.16

20.96

4.1

3.5

—

Other Crohn's disease

112

422

2.72

20.91

2.9

3.5

—

DVT of lower extremities

279

1517

1.87

20.89

4.5

3.6

—

Psychotic depression

317

3.00

20.89

3.7

3.8

—

FESS (DNB20)

186

879

2.16

20.85

3.9

3.6

—

Gingival hyperplasia

212

3.55

20.80

8.4

3.9

—

Renal agenesis and other reduction defects of kidney

9.68

20.69

10.5

3.3

—

5-aminosalicylic acid

268

1442

1.88

20.65

3.2

3.1

—

Gonarthrosis [arthrosis of knee](FG)

1034

4403

1.39

20.54

3.4

—

Systemic atrophies primarily affecting the central nervous system

296

3.10

20.46

4.6

3.9

—

Unspecified jaundice

318

2.98

20.27

4.2

4.4

—

Mixed disorders of conduct and emotions, excluding more controls

5.43

20.26

4.6

3.3

—

Urticaria and erythema

459

2882

1.61

20.22

4.0

3.5

—

Viral pneumonia (known virus, not influenza)

142

4.16

20.15

6.9

3.7

—

Decubitus ulcer and pressure area

110

420

2.71

20.14

6.3

3.8

—

Viral warts

152

672

2.31

20.12

6.0

3.5

—

Diseases of oral cavity, salivary glands and jaws

1334

5147

1.34

20.11

4.0

3.3

—

Persistent mood disorders

259

1394

1.88

20.00

4.6

3.5

—

Amyloidosis

109

4.64

19.92

6.0

3.4

—

Toxic effect of other and unspecified substances

6.20

19.90

4.8

3.0

—

Weight loss

160

727

2.25

19.90

4.1

3.9

—

Glaucoma

780

4804

1.44

19.85

3.8

3.7

—

Eating disorders

147

643

2.32

19.84

3.6

3.0

—

Coronary artery bypass grafting

416

1932

1.66

19.84

4.6

3.5

—

Secondary uncertain malignant neoplasm

206

1033

2.04

19.77

4.0

3.9

—

Oesophageal varices

287

3.08

19.64

5.0

4.3

—

Ethmoidectomy

190

928

2.09

19.56

3.8

3.6

—

Discitis, unspecified

103

4.77

19.51

5.5

4.0

—

Amyloidosis, other/unspecified

5.12

19.49

6.5

3.3

—

323

1770

1.75

19.48

4.1

3.7

—

Total colectomy

267

3.14

19.46

4.5

3.5

—

Total colectomy operation

267

3.14

19.46

4.5

3.5

—

Other eating disorders

272

3.09

19.38

3.5

2.8

—

Other disorders starting during childhood or adolecense, excluding more controls

188

3.51

19.36

5.1

3.3

—

Left bundle-branch block

104

393

2.71

19.33

3.3

2.9

—

Other spirochaetal diseases

2137

0.36

19.30

2.7

3.7

—

Superficial injury of abdomen, lower back and pelvis

216

1109

1.98

19.30

3.8

3.5

—

Methotrexate

190

932

2.07

19.27

2.9

3.1

—

Dental operations

964

3561

1.40

19.25

3.8

3.5

—

Other viral hepatitis

102

383

2.73

19.23

4.2

3.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

156

712

2.24

19.20

4.1

3.8

—

ILD medications: nintedanib

8.01

19.20

8.3

2.7

—

Disorders of tooth development and eruption

286

3.00

19.20

10.1

3.2

—

Other symptoms and signs involving the urinary system

166

777

2.18

19.17

4.4

4.0

—

Somatoform disorder

216

1112

1.97

19.13

4.1

3.4

—

Fracture of lumbar spine and pelvis

314

1815

1.75

19.10

3.8

3.6

—

Hepatic failure, not elsewhere classified

229

3.32

19.10

3.7

4.0

—

Insomnia

217

1120

1.97

19.09

3.6

3.5

—

Superficial injury of thorax

222

1156

1.95

19.06

3.9

—

Disorders of plasma-protein metabolism, not elsewhere classified

10.41

19.06

2.4

—

Astigmatism

102

385

2.72

19.01

5.8

3.9

—

Unstable angina pectoris

564

3103

1.52

18.98

4.4

3.6

—

Polyglandular dysfunction

19.33

18.98

8.9

1.5

—

Chronic periodontitis

224

1172

1.94

18.98

6.2

3.6

—

Lyme disease

2105

0.36

18.98

2.7

3.7

—

Other obstetric conditions, not elsewhere classified

324

1203

1.76

18.92

2.2

2.4

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

369

2160

1.67

18.88

3.6

3.7

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

683

3199

1.47

18.86

3.9

3.7

—

136

4.09

18.76

8.1

4.0

—

Allergic asthma (mode), excluding more controls

217

1102

1.95

18.75

2.9

2.4

—

Erosion of teeth

4.85

18.74

11.0

3.6

—

Colectomy operation

254

1391

1.86

18.70

4.0

3.7

—

Other diseases of hard tissues of teeth

842

4491

1.41

18.68

4.8

3.3

—

Crohn's disease of large intestine

300

2.95

18.65

3.6

3.4

—

Open wound of ankle and foot

161

753

2.18

18.63

4.6

3.9

—

Necrotizing fasciitis

11.91

18.60

3.6

4.3

—

Injuries to the shoulder and upper arm

1140

7201

1.33

18.53

3.8

3.6

—

Malignant neoplasm of respiratory system and intrathoracic organs

345

1897

1.70

18.49

3.9

3.8

—

Generalized anxiety disorder

178

866

2.08

18.44

2.8

3.2

—

Hyperaldosteronism

180

3.61

18.39

4.7

3.6

—

Carcinoma in situ of skin of other and unspecified parts of face

128

549

2.40

18.32

4.7

3.7

—

Disturbance of activity and attention

133

570

2.34

18.30

3.3

3.1

—

Thoracic aortic aneurysm

212

1104

1.96

18.29

4.2

3.6

—

Iron deficiency

5.07

18.20

2.1

2.7

—

Alcohol-induced acute pancreatitis

257

3.12

18.19

4.0

4.1

—

Other necrotizing vasculopathies

123

520

2.43

18.19

5.3

4.0

—

Excessive vomiting in pregnancy

101

388

2.65

18.14

2.7

2.8

—

ILD medications: pirfenidone

6.13

18.14

6.6

2.5

—

Polyarteritis nodosa and related conditions

5.13

18.08

3.6

3.5

—

Dermatographic urticaria

379

2.67

17.98

3.7

3.1

—

Polycystic ovarian syndrome, consortium definition

800

3427

1.42

17.86

3.4

3.0

—

Other and unspecified mood [affective] disorders

357

2.71

17.84

3.5

3.1

—

Urolithiasis

478

3125

1.55

17.81

3.8

—

Chronic ulcer of skin, not elsewhere classified

118

495

2.45

17.76

6.2

3.8

—

Hyperfunction of pituitary gland

244

3.11

17.71

4.8

2.5

—

Arterial embolism and thrombosis of lower extremity artery

245

3.14

17.70

4.7

3.8

—

Vascular diseases of the intestine

261

3.06

17.68

3.6

3.8

—

Type1 diabetes, definitions combined, early onset

108

433

2.54

17.67

3.4

3.7

—

Gonarthrosis

896

3727

1.39

17.58

3.4

3.5

—

Cholecystitis

206

1076

1.95

17.57

4.1

3.7

—

Fracture of lower leg, including ankle

709

4996

1.42

17.54

4.1

3.5

—

Sarcoidosis

195

1001

1.98

17.53

3.2

3.8

—

Diffuse large B-cell lymphoma, helper endpoint

268

3.01

17.48

4.0

3.6

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

268

3.01

17.48

4.0

3.6

—

Irritable bowel syndrome

335

2024

1.67

17.35

3.0

3.3

—

Other disorders of gingiva or/and edentulous alveolar ridge

313

2.83

17.30

8.0

4.1

—

Migraine with aura

239

1313

1.84

17.28

3.1

3.2

—

Radiculopathy

244

1353

1.83

17.26

3.9

3.4

—

Somnolence, stupor and coma

303

2.86

17.21

6.3

3.5

—

Abnormal weight loss

145

673

2.21

17.20

3.8

3.9

—

Postprocedural disorders of digestive system, not elsewhere classified

183

3.46

17.15

5.3

3.7

—

Disorders of purine and pyrimidine metabolism

9.69

17.10

7.0

2.2

—

Other problems related to primary support group, including family circumstances

147

667

2.18

17.09

6.3

3.4

—

Malignant neoplasm of digestive organs

552

3691

1.49

17.07

3.7

—

Lung transplant status

7.09

17.02

12.1

3.9

—

Lung transplantation

7.08

17.02

12.1

3.9

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

311

1177

1.73

17.01

2.3

2.4

—

Toxic effects of substances chiefly nonmedicinal as to source

168

828

2.07

16.95

3.4

3.9

—

Disorders of psychological development

162

726

2.10

16.92

3.8

3.6

—

Other necrotizing vasculopathies (FG)

101

404

2.57

16.86

5.3

3.2

—

Infection due to other mycobacteria

4.80

16.83

6.3

4.1

—

Folate deficiency anaemia

6.63

16.72

4.6

3.6

—

Mental retardation

253

3.02

16.70

4.8

4.0

—

Maternal care for other conditions predominantly related to pregnancy

209

1098

1.90

16.69

2.4

2.6

—

Use of biperiden

342

2.71

16.67

3.8

—

Open wound of forearm

143

670

2.18

16.53

4.2

3.6

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

148

703

2.15

16.51

6.4

4.3

—

Calculus of kidney and ureter

438

2863

1.55

16.39

3.9

3.8

—

Unknown and unspecified causes of morbidity

373

2.59

16.38

4.8

3.1

—

Suppurative and unspecified otitis media

441

2550

1.54

16.26

4.2

3.3

—

Arthrosis

974

3980

1.35

16.26

3.3

3.4

—

Dentofacial anomalies [including malocclusion]

317

1899

1.67

16.25

4.4

3.1

—

Injury of nerves and spinal cord at neck level

128

3.93

16.14

3.5

3.7

—

Superficial injury of hip and thigh

214

1164

1.87

16.14

4.1

3.7

—

Dental pulpitis 3

171

607

2.05

16.13

3.9

3.5

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

608

2886

1.46

16.11

4.1

3.7

—

Disorders of eyelid, lacrimal system and orbit

1120

6735

1.31

16.02

3.4

3.6

—

Spondyloarthritis

246

1398

1.78

16.01

4.0

3.6

—

Malignant neoplasm of bronchus and lung

296

1655

1.70

15.98

3.9

—

Other abnormalities of plasma proteins

4.70

15.93

5.8

3.0

—

Chronic periodontitis, complicated

148

714

2.12

15.92

6.8

4.1

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

115

502

2.36

15.91

3.8

4.0

—

Non-small cell lung cancer, adenocarcinoma

115

502

2.36

15.91

3.8

4.0

—

Rheumatism, unspecified

173

881

1.99

15.91

3.5

3.4

—

Respiratory disorders in diseases classified elsewhere

4.91

15.91

6.7

3.4

—

Right bundle-branch block

182

3.34

15.85

4.0

3.0

—

Amputation of ankle bones

144

3.72

15.83

11.1

3.7

—

Fracture of femur

380

2210

1.59

15.76

4.0

3.7

—

Non-follicular lymphoma

157

778

2.06

15.73

3.9

4.1

—

Urticaria

358

2255

1.60

15.73

4.0

3.4

—

Transport accidents

553

3374

1.46

15.70

3.3

3.4

—

severe traumatic brain injury, does not include concussion

322

1981

1.65

15.67

3.9

3.8

—

Impotence

401

2.52

15.66

5.3

4.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1059

4048

1.33

15.64

3.8

3.4

—

Injuries to the neck

293

1760

1.68

15.62

3.3

3.6

—

IBD patients in KELA-register

293

1760

1.68

15.60

3.1

3.6

—

Aortic valve malfunction, age under 60 years

137

647

2.16

15.56

6.4

4.2

—

Explicit fungal Sepsis

8.04

15.54

12.1

2.5

—

Heart failure and hypertrophic cardiomyopathy

114

4.09

15.49

7.0

3.4

—

Vitamin deficiency, wide

275

2.84

15.49

5.3

3.1

—

Vitamin deficiency

275

2.84

15.49

5.3

3.1

—

Disorders of adrenal gland, other and/or unspecified

10.45

15.49

3.0

2.4

—

Allergic asthma (mode)

217

1175

1.83

15.48

2.9

2.6

—

Viral hepatitis

107

457

2.39

15.47

4.2

3.4

—

Acute drug-induced interstitial lung disorder

6.63

15.46

4.2

3.0

—

Blood alcohol or alcohol intoxication level

156

3.54

15.41

3.3

2.9

—

Dermatitis due to substances taken internally

356

2.59

15.40

4.4

3.5

—

Papilloedema, unspecified

114

4.02

15.38

4.5

2.5

—

Benign neoplasm of other and unspecified endocrine glands

181

949

1.94

15.37

3.8

3.9

—

Other disorders of lacrimal gland

421

2767

1.54

15.35

3.5

3.6

—

Mental retardation, wide definition

271

2.85

15.33

4.7

4.2

—

Other or ill-defined heart diseases

260

2.87

15.26

4.4

2.9

—

Myalgia

271

1604

1.71

15.26

3.0

3.6

—

Pneumonia derived septicemia

229

3.03

15.22

6.0

3.6

—

Tracheo-bronchomalasia

15.15

15.22

2.3

3.8

—

Unspecified chronic bronchitis

218

3.07

15.20

5.1

4.0

—

Other disorders of nervous system

109

474

2.36

15.20

4.0

4.2

—

Traumatic subarachnoid haemorrhage

182

3.28

15.18

3.8

3.7

—

Pain in joint

699

3317

1.40

15.15

3.6

3.5

—

Benign neoplasm: Adrenal gland

101

425

2.43

15.13

3.8

3.5

—

6.87

15.11

4.3

1.6

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

261

1535

1.72

15.11

3.8

3.7

—

Other renal tubulo-interstitial diseases

111

4.01

15.08

5.5

2.1

—

Abscess of lung

4.47

15.05

6.9

2.8

—

Hyperkinetic disorders

139

659

2.11

15.01

3.2

3.3

—

Mixed hyperlipidaemia

258

2.88

14.99

4.6

3.6

—

Diseases of middle ear and mastoid

716

4254

1.39

14.98

4.0

3.3

—

Adult respiratory distress syndrome

4.89

14.96

9.0

3.3

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

10.00

14.95

7.9

2.5

—

Testicular dysfunction

226

3.02

14.94

4.0

3.8

—

Sicca syndrome [Sjögren]

121

553

2.23

14.93

3.2

3.4

—

Other abnormal findings of blood chemistry

281

2.79

14.93

4.2

4.0

—

Intestinal adhesions without obstruction

126

586

2.20

14.91

3.8

3.6

—

Acute suppurative otitis media

310

1781

1.64

14.86

4.5

3.3

—

Hypertrophy of (infrapatellar) fat pad

5.97

14.82

4.7

2.4

—

Emergency coronary revascularization (for ACS)

802

4255

1.36

14.81

4.7

3.7

—

Other diseases of arteries and capillaries

136

654

2.12

14.76

5.7

3.6

—

Other symptoms and signs involving cognitive functions and awareness

598

3974

1.42

14.72

3.6

3.7

—

Disorders of oesophagus in diseases classified elsewhere

118

3.91

14.72

5.2

3.6

—

Dental pulpitis 3, only avohilmo

157

569

2.04

14.65

3.7

3.6

—

Disorders of sclera, cornea, iris and ciliary body

686

4986

1.39

14.62

4.1

3.5

—

Disorders of phosphorus metabolism and phosphatases

10.41

14.58

3.8

2.2

—

Other ulcerative colitis

360

2.53

14.54

4.2

3.7

—

Secondary thrombocytopenia

5.15

14.50

5.2

3.8

—

Mental and behavioural disorders due to tobacco

122

567

2.20

14.47

5.2

3.8

—

Speech and linguistic disorders, excluding more controls

349

2.49

14.40

4.0

3.4

—

Other diseases of anus and rectum

388

2540

1.54

14.39

3.7

3.5

—

Other diseases of spinal cord

194

3.15

14.36

6.4

3.9

—

Speech disturbances, not elsewhere classified

138

675

2.09

14.36

4.1

3.9

—

Smoking dependency

122

569

2.19

14.35

5.2

3.8

—

Acute posthaemorrhagic anaemia

210

3.05

14.31

6.1

3.7

—

Special screening examination for infectious and parasitic diseases

1438

0.42

14.27

3.6

2.9

—

Inflammatory diseases of female pelvic organs

649

3512

1.40

14.27

3.5

3.0

—

Carcinoma in situ of skin, other sites/unspecified

4.96

14.27

5.3

3.2

—

Congenital malformations of cardiac septa

403

2.40

14.27

4.3

4.4

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

276

2.75

14.26

3.3

3.5

—

Mixed specific developmental disorders

115

3.78

14.23

5.1

6.1

—

Transient ischemic attack

697

4213

1.38

14.22

3.6

3.7

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

302

1879

1.63

14.10

3.9

3.5

—

Glaucoma suspect

464

3170

1.48

14.08

3.9

3.6

—

Cushing syndrome

5.31

14.06

3.6

1.8

—

Budesonide

162

843

1.95

14.05

3.9

3.2

—

Pneumococcal septicemia

218

2.99

14.04

6.1

3.7

—

Outcome of delivery

681

0.24

14.03

1.6

2.8

—

Asthma mixed form (mode), excluding more controls

206

3.01

14.03

2.6

2.5

—

Inflammatory bowel disease, strict (require KELA)

293

1811

1.63

14.01

3.1

3.5

—

Gingivitis and periodontal diseases

1255

5087

1.28

14.00

3.8

3.3

—

Disorders of lacrimal system

508

3534

1.45

13.98

3.4

3.6

—

Spinal stenosis

684

3905

1.38

13.94

3.5

3.7

—

Postmenopausal osteoporosis with pathological fracture

368

2.48

13.93

4.1

3.2

—

Rash and other nonspecific skin eruption

142

710

2.04

13.89

4.4

3.8

—

Mucosal proctocolitis

168

889

1.92

13.88

3.2

3.6

—

Testicular hypofunction

198

3.08

13.87

4.2

3.8

—

Other/unspecified mastoiditis and related conditions

7.96

13.86

2.2

2.5

—

Seropositive rheumatoid arthritis

313

1966

1.60

13.86

4.3

3.4

—

Hypoplasia of dental enamel , including avohilmo

145

3.45

13.81

13.4

3.5

—

Secondary and unspecified malignant neoplasm of lymph nodes

132

645

2.09

13.80

4.5

3.9

—

Atypical mycobacterium lung infection

4.81

13.78

6.6

2.9

—

Acute laryngitis and tracheitis

141

693

2.03

13.72

4.2

3.2

—

Colitis, primary sclerosing

5.00

13.72

4.1

2.5

—

Hypertension, Pulmonary Arterial

7.56

13.71

5.6

2.6

—

Diseases of male genital organs

798

2985

1.36

13.69

4.0

—

Migraine without aura and triptan purchases

169

900

1.90

13.65

2.7

3.0

—

Other follicular disorders

100

439

2.32

13.63

5.6

3.3

—

Disorders of muscles

135

667

2.06

13.62

3.9

3.8

—

Colitis, primary sclerosing, strict definition

5.87

13.54

2.8

2.6

—

Appendectomy

793

5741

1.34

13.52

3.4

3.5

—

Intentional self-harm by unspecified means

5.82

13.51

3.2

2.2

—

Schizotypal disorder

135

3.53

13.45

2.1

3.1

—

Other aneurysm

412

2.37

13.41

4.5

3.7

—

Crohn's disease of small intestine

411

2.36

13.40

2.9

3.5

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

131

3.60

13.39

7.1

3.9

—

Umbilical hernia

363

2385

1.54

13.38

4.6

3.7

—

Personal history of other diseases and conditions

119

563

2.13

13.28

3.8

2.6

—

Dissocial personality disorder

4.19

13.27

4.2

3.5

—

Biological medicines for asthma

5.16

13.27

4.4

3.0

—

Hodgkin lymphoma

146

3.40

13.26

5.6

3.2

—

Focal brain injury

370

2.42

13.22

3.3

3.7

—

Carcinoma in situ of skin of other and unspecified parts of face

128

630

2.08

13.18

4.7

3.9

—

Irregular menses

475

2661

1.46

13.18

3.3

2.9

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

9.91

13.15

4.4

2.0

—

Hypermetropia

102

459

2.27

13.13

5.8

3.9

—

Generalized skin eruption due to drugs and medicaments

226

2.87

13.13

4.4

3.7

—

Other abnormal findings in urine

4.17

13.11

5.6

4.0

—

Other inflammatory liver diseases

428

2.32

13.11

5.3

3.9

—

Other and unspecified glaucoma

111

519

2.19

13.05

3.1

3.8

—

Psoriatic and enteropathic arthropathies

151

788

1.94

13.05

3.0

3.2

—

Other factor of the environment

4.80

13.02

3.7

2.4

—

Diastasis of muscle

6.80

13.02

2.5

2.9

—

In situ neoplasms

454

3138

1.46

13.00

4.5

3.4

—

Benign paroxysmal vertigo

362

2393

1.53

12.98

3.8

3.6

—

Deforming dorsopathies

342

2233

1.54

12.95

3.4

3.6

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

437

2.30

12.95

3.2

3.8

—

Fitting and adjustment of external prosthetic device

10.91

12.89

19.0

1.6

—

Abnormal findings on diagnostic imaging of central nervous system

245

2.76

12.88

4.2

3.2

—

Other diseases of stomach and duodenum

445

2.28

12.83

5.6

3.8

—

Secondary malignant neoplasm of other and unspecified sites

4.30

12.81

4.0

3.8

—

Drug-induced osteoporosis

4.88

12.80

3.4

2.7

—

Lichen simplex chronicus and prurigo

434

2.29

12.71

6.4

3.6

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

568

2805

1.41

12.65

3.9

3.7

—

Other and unspecified injuries of lower leg

447

2.26

12.65

3.5

3.6

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

575

2838

1.40

12.65

3.8

3.7

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

3.94

12.60

2.3

3.2

—

Other immunodeficiencies

5.28

12.59

3.6

2.5

—

Polyarthrosis

243

1415

1.66

12.46

3.9

3.6

—

Abnormal blood-pressure reading, without diagnosis

210

2.87

12.44

2.6

3.3

—

Osteonecrosis

382

2.36

12.40

5.7

3.8

—

Molar incisor enamel hypoplasia

159

3.18

12.40

13.4

3.5

—

Prurigo nodularis

143

3.34

12.34

7.0

3.3

—

Hyperosmolality and hypernatraemia

4.58

12.34

5.8

3.1

—

Other and unspecified diseases of blood and blood-forming organs

143

3.34

12.33

5.6

3.5

—

Late syphilis

4.26

12.33

10.2

3.3

—

Pre-eclampsia or poor fetal growth

291

1848

1.58

12.31

3.4

2.7

—

Disorders of parathyroid gland, other and/or unspecified

5.47

12.24

7.7

2.8

—

Complications following infusion, transfusion and therapeutic injection

4.10

12.18

4.0

2.7

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

169

936

1.83

12.18

4.9

3.6

—

Syndrome of inappropriate secretion of antidiuretic hormone

7.22

12.18

2.8

—

Asthma and allergy, excluding more controls

111

525

2.11

12.12

2.6

2.5

—

Septal defects

395

2.30

12.12

4.1

4.4

—

Other misadventures during surgical and medical care

125

3.50

12.09

4.2

3.2

—

Benign neoplasm: Pancreas

135

3.38

12.05

4.0

3.9

—

Sequelae of injuries, of poisoning and of other consequences of external causes

293

1881

1.57

12.04

3.3

3.6

—

Metabolic disorder, other/unspecified

22.05

12.03

2.5

3.0

—

Wide developmental disorders, excluding more controls

109

3.62

12.00

2.7

3.9

—

Otitis media, unspecified

145

705

1.92

11.95

5.6

3.2

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

284

2.56

11.95

3.1

3.5

—

Acute generalized exanthematous pustulosis

261

2.63

11.93

4.5

3.7

—

Primary open-angle glaucoma, strict

358

2405

1.50

11.83

4.1

3.7

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

410

2827

1.46

11.79

3.4

3.5

—

Symptoms and signs involving speech and voice

401

2763

1.46

11.74

3.5

—

Disorder of lipoprotein metabolism, unspecified

175

991

1.79

11.73

4.9

3.6

—

Primary open-angle glaucoma

426

2893

1.45

11.72

3.8

3.7

—

Carcinoma in situ of skin, other sites/unspecified

4.21

11.71

5.3

4.2

—

Previous suicide attempt

5.51

11.69

3.6

2.8

—

Acute lymphadenitis

348

2.37

11.67

4.8

3.5

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

438

1851

1.46

11.61

3.8

4.0

—

Rheumatoid arthritis, including avohilmo

469

3333

1.42

11.58

3.8

3.6

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

666

4897

1.34

11.58

3.6

3.7

—

Other fall from one level to another

285

1835

1.57

11.56

3.3

3.9

—

Dental operations, only avohilmo

992

3974

1.28

11.54

3.7

—

Abnormality of white blood cells, not elsewhere classified

5.74

11.54

7.3

2.7

—

Disorders of skin appendages

554

4047

1.38

11.53

4.4

3.4

—

Diffuse large B-cell lymphoma

333

2.41

11.50

4.0

4.1

—

Otitis externa, unspecified

144

773

1.89

11.50

4.8

3.8

—

Thyrotoxicosis, other and/or unspecified

225

1371

1.66

11.50

3.1

3.3

—

Other (seronegative) rheumatoid arthritis, wide

243

1511

1.63

11.48

3.7

3.5

—

Monoamine oxidase A inhibitors

151

823

1.86

11.48

4.5

3.5

—

Paracetamol of NSAID medication

251

766

1.66

11.46

3.4

4.0

—

Follicular lymphoma

249

2.64

11.46

3.1

3.6

—

Asthma mixed form (mode)

231

2.68

11.43

2.6

2.8

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

447

2.19

11.42

3.5

3.7

—

Parkinson's disease, excluding more controls

164

894

1.81

11.40

3.5

3.6

—

Myopia

146

789

1.87

11.39

4.3

3.3

—

Functional dyspepsia

314

2073

1.53

11.38

3.5

3.4

—

Amenorrhoea

352

2.33

11.34

3.4

2.7

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

238

1477

1.63

11.34

3.3

3.7

—

Injuries to unspecified part of trunk, limb or body region

137

729

1.91

11.27

4.6

3.8

—

Drug-induced cataract

141

3.24

11.27

7.0

3.0

—

Brachial plexus disorders

111

549

2.05

11.25

2.7

3.3

—

ILD and respiratory illness in diseases classified elsewhere

7.44

11.24

7.1

2.8

—

Ovarian cyst

419

1669

1.46

11.23

3.2

3.1

—

Pure hyperglyceridaemia

111

3.54

11.23

3.5

3.6

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

133

702

1.93

11.21

3.6

3.8

—

Kyphosis

4.13

11.20

3.5

4.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

129

676

1.94

11.12

3.6

3.7

—

Hodgkin lymphoma, hilmo

163

3.04

11.11

5.6

3.3

—

Other coagulation defects

459

2.15

11.10

6.0

3.7

—

Personal history of risk-factors, not elsewhere classified

4.68

11.08

3.5

2.5

—

Melanocytic naevi, other sites/unspecified

446

2.17

11.08

6.0

3.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

314

2.40

11.07

4.9

3.7

—

Colorectal cancer

314

2088

1.52

11.06

3.7

—

Cardiomyopathy, Hypertrophic obstructive

3.95

11.04

8.5

3.6

—

Benign neoplasm: Colon, unspecified

286

1855

1.55

11.03

4.3

3.6

—

Heterophoria

103

500

2.09

11.01

4.0

3.5

—

Manic episode

175

2.94

10.96

5.7

3.2

—

Acute nephritic syndrome

128

3.32

10.96

7.0

3.0

—

4.19

10.95

3.9

1.7

—

Adhesive capsulitis of shoulder

209

1268

1.67

10.92

3.7

3.8

—

Thyroiditis, ILD-related definition

135

722

1.89

10.91

3.4

3.2

—

Autism spe, excluding more controls

3.97

10.90

1.6

3.0

—

Redundant prepuce, phimosis and paraphimosis

273

1758

1.56

10.90

3.8

3.9

—

Non-Hodgkin lymphoma, all

298

2.45

10.89

3.4

4.0

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

160

903

1.80

10.89

3.7

—

Injuries to the elbow and forearm

842

5943

1.29

10.87

3.8

3.5

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

438

2.17

10.80

2.9

3.9

—

Superficial injury of head

274

1778

1.55

10.77

3.8

3.6

—

Mixed disorders of conduct and emotions

124

3.32

10.77

4.6

3.3

—

Asthma and allergy

111

550

2.01

10.75

2.6

2.7

—

Pre-eclampsia

194

1158

1.69

10.75

3.4

2.7

—

Injuries to the wrist and hand

1268

7504

1.23

10.74

3.4

3.6

—

Cyst of kidney

105

520

2.06

10.72

5.5

3.7

—

Habit and impulse disorders

4.04

10.68

1.9

2.0

—

Asthma and opportunity respiratory infection

307

2.41

10.65

5.3

4.0

—

Hidradenitis suppurativa

189

2.82

10.63

6.0

2.8

—

Immunodeficiency with predominantly antibody defects

146

3.11

10.62

6.8

3.0

—

Scabies

289

2.44

10.60

5.4

3.4

—

Anorexia (incl.atypical)

363

2.27

10.60

4.0

3.1

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

320

2.36

10.58

3.3

3.7

—

Hypothermia

121

3.37

10.57

4.8

3.3

—

Sequelae of cerebrovascular disease

469

2967

1.40

10.56

3.9

3.7

—

Other arterial embolism and thrombosis

196

2.79

10.54

6.0

3.9

—

Acute bronchiolitis

336

2.26

10.54

6.9

3.6

—

Other noninfective disorders of lymphatic vessels and lymph nodes

190

2.81

10.54

5.4

3.5

—

Congenital malformations of the circulatory system

179

1019

1.72

10.52

5.0

3.9

—

Other disorders of veins

444

3181

1.40

10.46

4.5

3.5

—

Viral infections of the central nervous system

457

2.11

10.44

4.2

3.6

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

107

461

2.04

10.42

3.6

3.7

—

Benign neoplasm of middle ear and respiratory system

104

518

2.04

10.41

3.0

3.9

—

Cerebral palsy and other paralytic syndromes

150

843

1.80

10.38

4.6

3.8

—

Ulcerative rectosigmoiditis

107

539

2.02

10.37

3.5

3.7

—

Alzheimer disease, excluding more controls

215

874

1.66

10.36

3.5

3.6

—

Abnormal involuntary movements

165

954

1.75

10.35

3.5

3.9

—

Toxic effect of corrosive substances

7.19

10.35

3.1

4.8

—

Impetigo

268

2.48

10.33

3.8

3.0

—

Lifestyle-related condition

4.31

10.32

4.0

2.6

—

Diabetes mellitus in pregnancy

285

1203

1.55

10.29

2.6

—

Other shoulder lesions

109

554

1.99

10.28

3.8

3.6

—

Syphilis

160

2.97

10.25

8.0

3.5

—

Coxarthrosis [arthrosis of hip](FG)

669

3682

1.32

10.25

3.6

3.5

—

Dislocation, sprain and strain of joints and ligaments of head

210

2.67

10.23

4.3

3.4

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

5.34

10.22

4.3

1.7

—

Evidence of alcohol involvement determined by level of intoxication

4.52

10.19

3.6

2.4

—

Mild mental retardation

161

2.95

10.14

4.5

3.8

—

Visual field defects

122

649

1.91

10.12

4.3

3.8

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

3.55

10.12

8.4

2.8

—

Other conditions related to polyarteritis nodosa

10.55

10.11

2.8

3.8

—

Assault by unspecified means

109

3.41

10.10

3.8

3.6

—

Continuous positive airway pressure

151

733

1.79

10.08

5.1

2.9

—

Open wound of wrist and hand

532

3912

1.35

10.07

3.4

3.7

—

Psoriasis

343

2366

1.46

10.07

4.1

3.6

—

Wegener granulomatosis

3.63

10.04

5.4

3.2

—

7.02

10.02

7.4

2.8

—

Superficial injuries involving multiple body regions

146

3.03

9.99

2.8

2.6

—

Myeloid leukaemia

125

3.21

9.98

3.8

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

8.42

9.97

7.1

2.1

—

Autoimmune polyglandular failure

28.12

9.93

8.3

1.3

—

Osteomyelitis of vertebra

8.25

9.93

9.1

2.5

—

Seronegative rheumatoid arthritis

145

819

1.79

9.88

3.1

3.2

—

Sciatica+with lumbago

592

4249

1.33

9.87

3.3

3.5

—

Other/unspecified rheumatoid arthritis

165

968

1.73

9.87

4.4

3.6

—

Myocardial infarction, with ST-elevation

255

1665

1.55

9.86

5.0

3.8

—

Malignant neoplasm of skin

804

4749

1.28

9.86

3.8

3.7

—

Certain conditions originating in the perinatal period

104

465

2.01

9.83

6.5

3.2

—

Benign neoplasm of other and ill-defined parts of digestive system

194

1188

1.65

9.83

4.2

3.6

—

Congenital malformations of heart and great arteries

162

915

1.74

9.82

4.3

4.1

—

Use of trihexyphenidyl

26.61

9.81

6.5

2.2

—

Dental caries 2 and operation codes, only avohilmo

590

4825

0.76

9.79

2.9

3.7

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

418

1778

1.42

9.78

3.8

4.0

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

239

2.53

9.77

3.9

3.7

—

Herpesviral [herpes simplex] infections

142

801

1.80

9.74

5.1

3.5

—

Wet age-related macular degeneration

235

1484

1.57

9.71

3.6

3.7

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

102

3.46

9.71

4.7

3.1

—

Injuries involving multiple body regions

228

2.56

9.70

2.8

3.2

—

Urethral stricture

431

2.11

9.68

4.4

4.1

—

Hypermobility syndrome

264

2.43

9.66

2.7

—

Parodontitis or operation codes

1139

6858

1.23

9.65

3.9

3.6

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

179

1080

1.68

9.63

5.3

3.6

—

Cachexia

6.66

9.63

5.6

4.2

—

Benign neoplasm: Pancreas

155

2.94

9.62

4.0

3.9

—

Disorders of vestibular function (Vertigo)

558

4178

1.33

9.59

3.3

3.6

—

Iridocyclitis

274

1827

1.51

9.58

3.8

3.6

—

Disorders of optic nerve and visual pathways

117

625

1.90

9.58

3.8

3.5

—

Event of undetermined intent

393

2.15

9.55

4.2

3.6

—

Hyperplasia of prostate

543

2302

1.36

9.48

4.1

4.0

—

Other specified/unspecified soft tissue disorders

298

2.33

9.46

3.6

—

Vitamin D deficiency

3.60

9.45

3.6

2.4

—

Familial hypercholesterolemia

195

1209

1.63

9.43

3.4

3.5

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

162

2.86

9.43

4.4

3.4

—

Assault by other specified means

5.11

9.43

3.6

2.3

—

Pediculosis, acariasis and other infestations

389

2.15

9.41

5.0

3.6

—

Haemolytic anaemias

214

2.59

9.39

6.1

3.7

—

Chronic myeloproliferative disease

3.98

9.37

2.6

3.0

—

Acute and subacute iridocyclitis

235

1525

1.56

9.35

3.9

3.7

—

Diabetic neuropathy

210

1326

1.61

9.33

6.4

4.0

—

Visual disturbances

560

4243

1.33

9.32

3.8

3.6

—

Social phobias

457

2.04

9.29

2.1

3.0

—

Pyoderma gangrenosum

5.33

9.25

6.8

2.6

—

Parodontitis

1133

6860

1.22

9.19

3.9

3.6

—

Myocardial infarction, unclassifiable

328

2034

1.45

9.17

4.5

3.8

—

General examination and investigation of persons without complaint and reported diagnosis

946

4036

1.25

9.16

3.9

3.4

—

Pre-eclampsia or eclampsia

204

1287

1.60

9.15

3.4

2.9

—

Varicose veins

782

4665

1.27

9.15

4.0

3.5

—

Benign neoplasm of colon, rectum, anus and anal canal

781

5583

1.27

9.12

4.3

3.6

—

Neovascular glaucoma

272

2.37

9.11

5.4

3.7

—

Inflammatory diseases of the central nervous system

107

565

1.92

9.10

5.9

3.7

—

Defects in the complement system

5.81

9.10

2.9

2.1

—

Disorders of continuity of bone

109

579

1.91

9.09

4.8

3.5

—

Other and unspecified local infections of skin and subcutaneous tissue

120

658

1.85

9.08

6.3

3.7

—

Lesion of ulnar nerve

169

1021

1.67

9.08

3.8

3.9

—

Sequelae of injuries of upper limb

124

687

1.83

9.07

3.3

3.6

—

Secondary parkinsonism, excluding more controls

122

3.11

9.05

5.2

3.9

—

malignant neoplasm of male genital organs

599

2898

1.32

9.04

3.7

4.0

—

Neuralgia and neuritis, unspecified

279

2.34

9.02

2.6

3.6

—

Assault by sharp object

3.42

9.01

6.3

3.8

—

Visual disturbances and blindness

605

4656

1.31

9.00

3.9

3.6

—

Other and unspecified coagulation defects

267

2.37

9.00

5.3

3.5

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

311

2155

1.46

8.99

4.3

3.6

—

Other symptoms and signs involving general sensations and perceptions

249

2.43

8.98

5.0

3.5

—

Other local infections of skin and subcutaneous tissue

127

711

1.81

8.98

6.2

3.6

—

Migraine with aura and triptan purchases

151

888

1.72

8.94

2.3

3.1

—

Pulmonary oedema

118

3.17

8.94

7.4

4.1

—

Psoriatic arthropathies

123

683

1.82

8.93

3.0

3.2

—

Fracture of skull and facial bones

246

1629

1.52

8.92

3.1

3.8

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

182

1105

1.63

8.91

3.2

3.4

—

Benign neoplasm: Adrenal gland

101

528

1.95

8.90

3.8

—

Ulcerative colitis (strict definition, require KELA)

198

1250

1.60

8.90

3.3

3.7

—

Scoliosis

101

527

1.94

8.90

4.0

3.4

—

Evidence of alcohol involvement determined by blood alcohol level

3.55

8.89

3.0

2.5

—

Diseases of spleen

3.46

8.87

4.9

3.6

—

Acquired haemolytic anaemia

140

2.95

8.86

6.0

3.7

—

Adalimumab

104

549

1.92

8.86

2.8

3.5

—

Missing teeth due to accident, extraction or parodontitis

144

840

1.74

8.84

4.3

3.5

—

Assault by bodily force

480

1.99

8.83

3.3

3.1

—

Glaucoma secondary to other eye disorders

276

2.34

8.83

5.4

4.0

—

Colorectal adenocarcinoma

261

1756

1.50

8.82

3.8

—

Biological medication for rheuma

174

1068

1.65

8.78

2.7

3.6

—

Cluster headache, wide

168

2.73

8.78

4.8

3.1

—

Other specific joint derangements/joint disorders

858

4605

1.25

8.75

3.7

3.4

—

Other abnormal uterine and vaginal bleeding

260

1234

1.51

8.75

3.4

3.3

—

Other and unspecified mental retardation

3.42

8.73

4.0

4.9

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

211

1359

1.57

8.71

3.3

3.6

—

Myositis

136

2.95

8.68

4.7

4.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

191

1204

1.60

8.66

3.3

3.7

—

Polycythaemia vera

193

2.60

8.65

3.7

—

Poisoning by medicine, drug-induced

3.93

8.62

3.1

2.6

—

Exposure to other specified factors

891

6765

1.24

8.60

3.6

—

Chronic sinusitis

509

3849

1.33

8.59

3.7

3.5

—

Papulosquamous disorders

458

3414

1.35

8.58

4.0

3.6

—

Malignant neoplasm of prostate

586

2832

1.32

8.58

3.6

4.0

—

Paralytic ileus

261

2.35

8.56

4.1

3.7

—

Chronic periodontitis, including avohilmo

1121

6861

1.21

8.51

3.9

3.6

—

Seborrhoeic dermatitis

126

716

1.79

8.51

6.1

3.7

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

172

2.69

8.46

4.2

3.8

—

Keratitis

407

2987

1.37

8.44

4.5

3.5

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.86

8.43

1.7

2.7

—

Complications of genitourinary prosthetic devices, implants and grafts

133

2.94

8.41

3.6

—

Sequelae of infectious and parasitic diseases

524

1.92

8.40

4.3

3.7

—

Abscess of anal and rectal regions

106

574

1.87

8.38

3.7

3.8

—

Other disorders of amino-acid metabolism

6.55

8.32

4.9

5.1

—

Microscopic polyangiitis

5.40

8.31

9.0

2.9

—

Other disorders starting during childhood or adolescence

306

2.21

8.30

5.1

4.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

349

2.14

8.30

3.6

4.0

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

3.44

8.30

4.5

3.6

—

Polyuria

266

1819

1.48

8.29

3.3

3.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

703

4387

1.27

8.27

3.9

3.7

—

Thyrotoxicosis

278

1918

1.46

8.26

3.0

3.4

—

Soft tissue disorders related to use, overuse and pressure

305

2143

1.43

8.21

4.0

3.6

—

Hepatomegaly and splenomegaly, not elsewhere classified

4.94

8.21

7.3

3.2

—

Other/unspecified seropositive rheumatoid arthritis

312

2202

1.43

8.21

4.3

3.6

—

IBD (strict) with PSC

4.93

8.20

5.8

3.1

—

Strabismus

303

2123

1.44

8.20

4.7

3.6

—

Other congenital malformations

101

542

1.89

8.20

4.8

3.8

—

Anterior Iridocyclitis

244

1645

1.50

8.18

3.9

3.7

—

Extrapyramidal and movement disorders

450

3374

1.34

8.15

3.7

—

Tumor necrosis factor alpha inhibitors

154

936

1.66

8.12

2.8

3.6

—

Malignant neoplasm of other and unspecified parts of biliary tract

3.67

8.09

2.3

2.9

—

Any dementia, excluding more controls

448

2315

1.35

8.09

3.2

3.7

—

Early complications of trauma

274

2.27

8.09

5.3

3.5

—

!Aliquae complicationes praecoces traumatis

274

2.27

8.09

5.3

3.5

—

Hydrocephalus in other diseases

5.54

8.08

6.4

2.8

—

Spondylopathies (FG)

158

968

1.65

8.08

3.0

3.2

—

Other and unspecified spinal muscular atrophies

4.49

8.07

4.1

4.2

—

Malignant neoplasm of small intestine

131

2.92

8.07

4.9

3.9

—

Allergic urticaria

510

1.91

8.06

3.9

3.3

—

Acetic acid derivatives and related substances

443

1702

1.36

8.05

3.8

4.3

—

Nonsuppurative otitis media

263

1553

1.47

8.05

4.8

3.3

—

Myeloproliferative diseases

115

648

1.80

8.04

3.5

3.9

—

Presence of other devices

101

1797

0.56

7.99

2.5

3.5

—

Pain and other conditions associated with female genital organs and menstrual cycle

195

1206

1.56

7.97

2.0

3.0

—

Seropositive rheumatoid arthritis, wide

313

2223

1.42

7.96

4.3

3.6

—

Oesophagitis

375

2.06

7.94

4.8

4.0

—

Symptoms and signs involving emotional state

166

2.65

7.92

4.3

3.7

—

Other and unspecified psoriasis

451

1.96

7.90

3.8

3.7

—

Chronic hepatitis, not elsewhere classified

178

2.58

7.89

5.5

3.1

—

Arthropathic psoriasis

132

777

1.72

7.89

3.6

3.8

—

Striking against or struck by other objects

378

2773

1.37

7.88

3.4

3.8

—

Coxarthrosis

613

3244

1.29

7.85

3.7

3.6

—

Vitamin B12 deficiency anaemia

142

854

1.68

7.85

3.9

3.5

—

Impaction of intestines

5.64

7.83

3.3

4.0

—

Hyperhidrosis

111

3.03

7.81

3.0

2.6

—

Injury of unspecified body region

538

1.87

7.79

4.6

3.9

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

3.47

7.77

3.3

3.8

—

Follicular lymphoma, hilmo

299

2.19

7.75

3.1

4.0

—

Acute gastritis

539

1.86

7.74

4.8

3.6

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.50

7.72

1.7

2.2

—

Other neurotic disorders

332

2.12

7.72

4.6

3.9

—

Carcinoma in situ of other and unspecified sites

242

2.34

7.71

3.0

4.0

—

Anankastic personality disorder

186

2.52

7.70

1.7

2.8

—

Need for other prophylactic measures

359

2.07

7.70

3.8

4.1

—

Fall on and from stairs and steps

296

2095

1.42

7.70

4.1

3.7

—

Squamous cell neoplasms and carcinomas of the skin

169

1068

1.60

7.68

4.9

3.9

—

Persistent delusional disorders

519

1.88

7.68

3.5

3.6

—

Parodontitis and operation codes

1046

6758

1.21

7.67

3.9

3.6

—

Faecal incontinence

526

1.87

7.67

3.6

—

Orchitis and epididymitis

127

747

1.72

7.64

4.3

4.2

—

Disorders of vitreous body and globe

583

4454

1.28

7.63

4.6

3.7

—

Viral encephalitis, not elsewhere classified/unspecified

124

2.91

7.63

5.3

3.6

—

Magnesium deficiency

14.97

7.61

3.7

2.1

—

Amiodarone users

141

855

1.67

7.60

3.7

4.1

—

Hypertrophic cardiomyopathy

295

2.19

7.60

6.5

4.1

—

Unspecified misadventure during surgical and medical care

368

2.05

7.59

4.6

3.7

—

Dislocation, sprain and strain of joints and ligaments at neck level

165

1040

1.60

7.55

2.8

3.4

—

Paraplegia, diplegia of upper limbs

136

2.80

7.54

4.0

3.1

—

Osteonecrosis due to drugs

3.69

7.54

3.5

2.7

—

Other and unspecified injuries of ankle and foot

244

2.30

7.52

4.7

3.3

—

Preterm labour and delivery

234

1591

1.48

7.52

3.0

3.2

—

Injury of other and unspecified intrathoracic organs

488

1.90

7.50

4.2

4.0

—

Melanocytic naevi, other sites/unspecified

516

1.87

7.50

6.0

3.7

—

Chronic laryngitis and laryngotracheitis

174

1114

1.58

7.47

3.8

3.5

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

432

1.95

7.46

2.6

3.5

—

Amputation of foot

190

2.50

7.46

8.7

3.8

—

Other congenital malformations of heart

6.18

7.46

2.0

4.7

—

Primary gonarthrosis, bilateral

621

4298

1.27

7.42

3.2

3.8

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

208

2.40

7.41

5.2

2.9

—

Parkinson's disease, strict definition, excluding more controls

138

820

1.67

7.39

3.3

3.6

—

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

291

2.17

7.39

2.8

3.5

—

Hypersensitivity angiitis

5.76

7.37

4.9

3.2

—

Excessive, frequent and irregular menstruation

424

1756

1.35

7.37

3.0

3.1

—

Superficial injury of wrist and hand

213

1429

1.50

7.35

3.7

—

Other and unspecified abdominal hernia

286

2.18

7.33

4.3

4.0

—

Hypoplasia of dental enamel, prenatal

8.91

7.33

18.7

6.8

—

Oesophageal obstruction

241

2.29

7.32

3.3

4.1

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

179

2.52

7.32

4.3

4.2

—

Urethritis and urethral syndrome

116

2.92

7.28

4.7

3.1

—

Disorders of vitreous body

561

4309

1.28

7.28

4.6

3.7

—

Haemolytic-uraemic syndrome

8.53

7.27

9.2

3.4

—

Malignant neoplasm of mesothelium and soft tissue

314

2.12

7.25

2.6

4.3

—

Superficial injury of ankle and foot

129

773

1.69

7.24

4.1

3.6

—

Congenital iodine-deficiency syndrome/hypothyroidism

174

2.53

7.24

3.9

3.5

—

Ehlers-Danlos syndrome

4.88

7.23

1.9

1.7

—

Other orthopaedic follow-up care

314

2.10

7.20

2.5

3.1

—

Other disorders of optic [2nd] nerve and visual pathways

417

1.95

7.19

4.3

3.7

—

Other bursopathies

156

983

1.60

7.19

4.9

3.9

—

Use of riluzole

5.71

7.15

4.8

2.8

—

Carcinoma in situ, bladder

219

2.35

7.11

2.9

3.9

—

Crohn disease (strict definition, require KELA)

405

1.95

7.08

2.6

3.5

—

Tobacco use

337

2.05

7.06

4.7

3.7

—

Anosmia

4.71

7.05

4.2

1.6

—

Cluster headache, strict

158

2.58

7.05

5.2

3.0

—

Normotensive glaucoma

111

645

1.75

7.05

3.1

3.7

—

Other specified congenital malformation syndromes affecting multiple systems

3.30

7.04

6.9

4.4

—

Bacterial, viral and other infectious agents

102

578

1.79

7.03

4.5

3.9

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

140

865

1.64

7.02

3.8

3.6

—

Use of antiglaucoma preparations and miotics

107

616

1.76

7.01

3.9

—

Gonarthrosis, primary, with knee surgery

699

4608

1.25

6.99

3.4

3.8

—

Pneumoconiosis due to asbestos and other mineral fibres

178

2.49

6.96

3.5

3.6

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

471

1.87

6.96

4.7

3.6

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

5.96

6.94

3.8

4.8

—

Mesothelioma, excluding all cancers (controls excluding all cancers)

3.46

6.93

3.5

3.8

—

Nonischemic cardiomyopathy

381

1.98

6.92

3.4

3.7

—

Artificial joint operation, meniscal resection

1156

6505

1.19

6.89

3.4

3.7

—

Pilonidal cyst

545

1.80

6.88

3.2

3.3

—

Other maternal disorders predominantly related to pregnancy

520

2539

1.29

6.87

2.9

3.1

—

Mantle cell lymphoma

3.70

6.86

3.5

3.9

—

Peptic ulcer

3.78

6.85

3.0

3.4

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

4.43

6.84

2.2

2.5

—

Hypertension, portal

7.81

6.82

5.0

2.3

—

Other and unspecified trigeminal disorders

3.17

6.82

1.6

3.2

—

Abnormal reflex

5.02

6.82

5.3

2.6

—

Osteopathy in diseases classified elsewhere

4.70

6.82

3.7

2.5

—

Benign neoplasm: Skin, unspecified

210

2.33

6.82

3.6

3.4

—

Benign neoplasm: Endocrine pancreas

5.30

6.81

4.8

3.2

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

4.05

6.80

5.1

3.0

—

Atopic dermatitis, strict definition with reimbursement

301

2116

1.39

6.80

4.6

3.2

—

Primary biliary cholangitis (PBC)

3.14

6.79

6.1

3.6

—

Olecranon bursitis

455

1.88

6.75

5.5

4.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

391

1.95

6.75

2.7

3.4

—

Coxibs

427

1717

1.33

6.75

3.2

4.3

—

Other and unspecified follicular disorders

244

2.22

6.69

5.0

3.2

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

244

2.21

6.68

2.6

3.5

—

Cryoglobulinemia

16.98

6.68

5.2

4.6

—

Heartburn

105

609

1.74

6.68

3.6

3.7

—

Chorioretinal inflammation

163

2.51

6.66

3.6

3.3

—

Recurrent and persistent haematuria

3.99

6.64

5.2

1.8

—

Car occupant injured in other and unspecified transport accidents

206

1404

1.48

6.63

3.6

3.5

—

Benign neoplasm: Skin of trunk

219

2.28

6.63

3.6

3.3

—

Other specified/unspecified inflammatory spondylopathies

251

2.18

6.63

2.3

3.4

—

Degenerative macular diseases

157

1013

1.57

6.60

3.9

3.8

—

Exclusion endpoint for clefts

3.02

6.59

6.6

5.1

—

Other specified/unspecified spondylopathies

152

2.56

6.59

4.8

4.1

—

Other and unspecified epidermal thickening

146

2.59

6.59

6.0

4.2

—

Carcinoma in situ of prostate

5.13

6.56

4.4

2.7

—

Mental and behavioural disorders due to hallucinogens

5.12

6.56

7.4

1.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

202

1375

1.48

6.55

3.9

3.7

—

Excessive attrition of teeth

478

2001

1.30

6.54

4.1

3.1

—

Ulcerative colitis (strict) with PSC

4.74

6.53

3.8

3.3

—

Other and unspecified immunodeficiencies with predominantly antibody defects

3.63

6.52

9.3

2.4

—

Other disorders of eyelid

527

4023

1.27

6.51

3.1

3.7

—

Dermatophytosis

156

1008

1.56

6.51

5.0

3.9

—

Generalized epilepsy

247

2.18

6.48

4.0

3.7

—

Cardiac murmurs and other cardiac sounds

541

1.77

6.48

3.8

3.5

—

Trigger finger

150

962

1.57

6.45

3.5

3.6

—

Other noninflammatory disorders of vulva and perineum

534

1.78

6.45

4.0

3.1

—

Other female pelvic inflammatory diseases

161

1049

1.55

6.45

2.6

3.0

—

Other and unspecified hydrocephalus

119

2.77

6.43

5.8

3.4

—

Benign neoplasm of middle ear and respiratory system

104

610

1.73

6.42

3.0

4.0

—

Appendicitis, broad definition

878

6697

1.20

6.41

3.6

—

Infection of intervertebral disc (pyogenic)

3.28

6.39

4.2

—

Obsessive-compulsive disorder

329

2.00

6.37

2.5

2.8

—

Familial hypercholesterolemia, with ischemic heart disease

119

725

1.66

6.36

3.7

—

Acne

104

610

1.72

6.36

7.3

2.8

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

131

2.66

6.36

3.4

3.5

—

Other disorders of bone

215

1491

1.45

6.34

4.2

3.5

—

Sequelae of other and unspecified infectious and parasitic diseases

330

2.00

6.34

4.5

3.2

—

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

3.02

6.34

3.1

3.0

—

Malignant neoplasm of brain

211

2.28

6.33

2.3

3.4

—

Mixed connective tissue disease

379

1.93

6.33

5.1

3.8

—

Ulcerative enterocolitis

192

2.34

6.32

3.3

3.5

—

3.00

6.32

3.7

3.0

—

Diseases of appendix

885

6742

1.20

6.31

3.6

—

Malignant immunoproliferative diseases

3.82

6.30

5.0

3.0

—

Autism

126

2.68

6.28

2.3

3.4

—

Conjunctivitis (acute, non atopic)

298

2183

1.37

6.27

4.3

3.6

—

Juvenile arthritis (FINNGEN)

257

2.13

6.27

4.1

3.4

—

Infections with a predominantly sexual mode of transmission

294

2154

1.37

6.26

4.8

3.2

—

Haemorrhage in early pregnancy

239

1651

1.42

6.26

2.6

3.0

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

332

1.99

6.26

4.5

4.1

—

Other bacterial agents as the cause of diseases classified to other chapters

3.66

6.25

8.3

2.6

—

Other strabismus

234

1648

1.43

6.25

4.9

3.5

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

4.12

6.25

4.9

2.5

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

113

682

1.67

6.25

4.4

3.9

—

TMD muscular pain linked with fibromyalgia

4.11

6.25

3.0

2.1

—

Acquired absence of organs, not elsewhere classified

3.63

6.23

8.0

3.1

—

Postprocedural disorders of nervous system

395

1.89

6.22

3.6

2.9

—

Henoch-Schönlein purpura nephritis (HSPN)

6.23

6.22

8.3

2.4

—

Carcinoma in situ of skin of trunk

175

2.40

6.21

4.9

4.1

—

Benign neoplasm: Bronchus and lung

3.50

6.21

2.5

3.2

—

Benign neoplasm of eye and adnexa

105

623

1.70

6.20

3.5

3.7

—

Leiomyoma of uterus

413

1774

1.32

6.20

3.1

3.0

—

Unspecified/other endometriosis

467

1.81

6.20

2.7

—

SLE (Finngen)

151

2.49

6.14

4.3

3.3

—

Other and unspecified diseases of spleen

5.60

6.12

4.3

3.1

—

Acute nasopharyngitis (common cold)

132

828

1.60

6.10

2.8

3.4

—

Salpingitis and oophoritis

172

1151

1.51

6.10

4.6

3.0

—

Malignant neoplasm of colon

184

1250

1.49

6.10

3.6

3.9

—

Volvulus

158

2.46

6.10

4.8

3.9

—

Use of rotigotine

3.59

6.09

5.0

3.1

—

Poor fetal growth

102

603

1.70

6.08

3.5

2.4

—

Artrosis, including avohilmo

1105

5154

1.18

6.08

3.2

3.7

—

Small fibre neuropathy

177

2.38

6.07

4.5

3.8

—

Benign neoplasm: Colon

636

5072

1.23

6.06

4.3

3.7

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

185

1259

1.48

6.06

3.4

3.7

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

183

2.33

6.03

5.6

3.7

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

378

1.90

6.03

2.6

2.2

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Gas panel - Central venous blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS